Protein,Protein_definition,Trait_category,Trait,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
PLA2G15,Phospholipase A2 group XV,Lifestyle factors,X1050.Time spend outdoors in summer,46225,0.111858994914414,0.0304312231352207,0.0522137975693817,0.171504192259447,0.000237376286462764
PLA2G15,Phospholipase A2 group XV,Lifestyle factors,X1060.Time spent outdoors in winter,40307,-0.0256517890381316,0.0340830741991514,-0.0924546144684684,0.0411510363922052,0.451679417076956
PLA2G15,Phospholipase A2 group XV,Physical activities,X1070.Time spent watching television (TV),48612,0.285218901485612,0.0306872860419461,0.225071820843397,0.345365982127826,1.54008955828853e-20
PLA2G15,Phospholipase A2 group XV,Physical activities,X1080.Time spent using computer,40338,-0.174085378656946,0.0314065917033591,-0.23564229839553,-0.112528458918362,2.99263697526495e-08
PLA2G15,Phospholipase A2 group XV,Physical activities,X1090.Time spent driving,34972,-0.155557574967976,0.0343317264723192,-0.222847758853721,-0.08826739108223,5.88950365186297e-06
PLA2G15,Phospholipase A2 group XV,Lifestyle factors,X1160.Sleep duration,51227,0.0154898424422063,0.0276944557185497,-0.0387912907661511,0.0697709756505637,0.575951227720487
PLA2G15,Phospholipase A2 group XV,Health and medical history,X120039#0.Location of pain during the past week_None of the given areas,17158,0.00139621876139201,0.00719854072610119,-0.0127129210617663,0.0155053585845503,0.84621060966501
PLA2G15,Phospholipase A2 group XV,Health and medical history,X120039#1.Location of pain during the past week_Left shoulder,17158,0.0184610719355722,0.00701444469248562,0.00471276033830035,0.032209383532844,0.00849936301604877
PLA2G15,Phospholipase A2 group XV,Health and medical history,X120039#10.Location of pain during the past week_Upper right leg,17158,0.0203221473593864,0.00802396392334152,0.00459517806963701,0.0360491166491358,0.0113282088357567
PLA2G15,Phospholipase A2 group XV,Health and medical history,X120039#11.Location of pain during the past week_Lower left leg,17158,0.0193765312750936,0.00822040473785459,0.00326453798889865,0.0354885245612886,0.0184281651538352
PLA2G15,Phospholipase A2 group XV,Health and medical history,X120039#12.Location of pain during the past week_Lower right leg,17158,0.0223911281477711,0.00834666964194064,0.00603165564956741,0.0387506006459747,0.00731131320266584
PLA2G15,Phospholipase A2 group XV,Health and medical history,X120039#13.Location of pain during the past week_Left jaw pain,17158,0.00853505574921259,0.0180097475257964,-0.0267640494013483,0.0438341608997735,0.63556789368918
PLA2G15,Phospholipase A2 group XV,Health and medical history,X120039#14.Location of pain during the past week_Right jaw pain,17158,0.0222333757823754,0.0184511242745651,-0.0139308277957722,0.0583975793605231,0.228224725374665
PLA2G15,Phospholipase A2 group XV,Health and medical history,X120039#15.Location of pain during the past week_Chest pain,17158,0.00937352308738679,0.0126233387824578,-0.0153682209262305,0.034115267101004,0.457761326780508
PLA2G15,Phospholipase A2 group XV,Health and medical history,X120039#16.Location of pain during the past week_Abdomen,17158,0.0194487881297609,0.00925031576969619,0.0013181692211564,0.0375794070383655,0.0355240502583337
PLA2G15,Phospholipase A2 group XV,Health and medical history,X120039#17.Location of pain during the past week_Neck pain,17158,0.0198071664879504,0.00634709405926239,0.00736686213179611,0.0322474708441047,0.00180741544522087
PLA2G15,Phospholipase A2 group XV,Health and medical history,X120039#18.Location of pain during the past week_Upper back,17158,0.0165409926349097,0.00918764216510133,-0.0014667860086889,0.0345487712785083,0.0718225995372033
PLA2G15,Phospholipase A2 group XV,Health and medical history,X120039#19.Location of pain during the past week_Lower back,17158,0.00562647766530361,0.00514305169004855,-0.00445390364719154,0.0157068589777988,0.273972129495376
PLA2G15,Phospholipase A2 group XV,Health and medical history,X120039#2.Location of pain during the past week_Right shoulder,17158,0.00649211823376017,0.00664677102947303,-0.00653555298400697,0.0195197894515273,0.328715311935835
PLA2G15,Phospholipase A2 group XV,Health and medical history,X120039#3.Location of pain during the past week_Upper left arm,17158,0.0219693048217248,0.0098244434661294,0.00271339562811116,0.0412252140153384,0.0253522568238599
PLA2G15,Phospholipase A2 group XV,Health and medical history,X120039#4.Location of pain during the past week_Upper right arm,17158,0.00858597029637594,0.00928789499560554,-0.00961830389501092,0.0267902444877628,0.355277648110681
PLA2G15,Phospholipase A2 group XV,Health and medical history,X120039#5.Location of pain during the past week_Lower left arm,17158,0.024881816628513,0.012484927492092,0.000411358744012696,0.0493522745130132,0.0462829185774372
PLA2G15,Phospholipase A2 group XV,Health and medical history,X120039#6.Location of pain during the past week_Lower right arm,17158,0.0152970397830271,0.0117682088300662,-0.00776864952390274,0.0383627290899569,0.193665971345209
PLA2G15,Phospholipase A2 group XV,Health and medical history,X120039#7.Location of pain during the past week_Left hip,17158,0.00291675590086344,0.00721260877316227,-0.0112199572945346,0.0170534690962615,0.685925998401407
PLA2G15,Phospholipase A2 group XV,Health and medical history,X120039#8.Location of pain during the past week_Right hip,17158,0.014466482209901,0.00684542254825921,0.00104945401531298,0.0278835104044891,0.0345888736439504
PLA2G15,Phospholipase A2 group XV,Health and medical history,X120039#9.Location of pain during the past week_Upper left leg,17158,0.0136072934677568,0.00855278079562554,-0.00315615689166923,0.0303707438271829,0.111632770378333
PLA2G15,Phospholipase A2 group XV,Health and medical history,X120040.Fatigue severity over the past week,17170,0.300525478451153,0.0515935036243502,0.199402211347426,0.401648745554879,5.81794007122368e-09
PLA2G15,Phospholipase A2 group XV,Health and medical history,X120041.Waking unrefreshed severity over the past week,17170,0.192837879743209,0.050907934568675,0.0930583279886056,0.292617431497812,0.00015239982624411
PLA2G15,Phospholipase A2 group XV,Health and medical history,X120042.Cognitive symptoms severity over the past week,17170,0.20226577948916,0.0553224264923111,0.0938338235642307,0.31069773541409,0.000256820240711639
PLA2G15,Phospholipase A2 group XV,Health and medical history,X120098.Mobility problems today,17179,0.365884991898459,0.0600993066386475,0.24809035088671,0.483679632910208,1.16756908670241e-09
PLA2G15,Phospholipase A2 group XV,Health and medical history,X120099.Self-care problems today,17179,0.322684430704297,0.0918657848305938,0.142627492436333,0.502741368972261,0.000444946207012207
PLA2G15,Phospholipase A2 group XV,Health and medical history,X120100.Problems doing usual activities,17179,0.200362965858667,0.0571314668345171,0.0883852908630138,0.312340640854321,0.000454260224254818
PLA2G15,Phospholipase A2 group XV,Health and medical history,X120101.Pain or discomfort today,17179,0.132456376682441,0.051449667030221,0.0316150293032082,0.233297724061674,0.0100472579300174
PLA2G15,Phospholipase A2 group XV,Health and medical history,X120102.Anxiety or depression today,17179,0.207510934209204,0.0620835208400821,0.085827233362643,0.329194635055765,0.000832203842574004
PLA2G15,Phospholipase A2 group XV,Health and medical history,X120103.Scale to indicate how health is today,17123,-0.0138916555765051,0.00222675972479263,-0.0182561046370987,-0.00952720651591158,4.52146944461842e-10
PLA2G15,Phospholipase A2 group XV,Health and medical history,X120104.Little interest or pleasure in doing things over the last two weeks,17138,0.232316879636715,0.0623700478356743,0.110071585878793,0.354562173394637,0.000196086085028423
PLA2G15,Phospholipase A2 group XV,Health and medical history,"X120105.Feeling down, depressed, or hopeless over the last two weeks",17113,0.20669569657516,0.0644154303705992,0.0804414530487851,0.332949940101534,0.00133539872509503
PLA2G15,Phospholipase A2 group XV,Health and medical history,"X120106.Trouble falling or staying asleep, or sleeping too much over the last two weeks",17149,0.129525556551216,0.0510531367007769,0.0294614086176936,0.229589704484739,0.01118714295658
PLA2G15,Phospholipase A2 group XV,Health and medical history,X120107.Feeling tired or having little energy over the last two weeks,17150,0.291882454228058,0.0521937025716019,0.189582797187719,0.394182111268398,2.27512416340671e-08
PLA2G15,Phospholipase A2 group XV,Health and medical history,X120108.Poor appetite or overeating over the last two weeks,17156,0.261948071982996,0.0668417990264444,0.130938145891165,0.392957998074827,8.92898427597425e-05
PLA2G15,Phospholipase A2 group XV,Health and medical history,X120109.Feeling bad about self over the last two weeks,17109,0.11563339610645,0.0673184321512636,-0.0163107309100269,0.247577523122926,0.0858680376609493
PLA2G15,Phospholipase A2 group XV,Health and medical history,X120110.Trouble concentrating over the last two weeks,17155,0.17803111404201,0.0674003631915486,0.0459264021865743,0.310135825897445,0.00826398429023331
PLA2G15,Phospholipase A2 group XV,Health and medical history,X120111.Moving or speaking slower or faster than usual over the last two weeks,17139,0.311537555247462,0.0981906240635236,0.119083932082956,0.503991178411968,0.0015125197838332
PLA2G15,Phospholipase A2 group XV,Health and medical history,X120112.Thoughts of being better off dead or of hurting self over the last two weeks,17066,0.179204060598037,0.13407410734865,-0.0835811898053177,0.441989311001391,0.181369591418692
PLA2G15,Phospholipase A2 group XV,Health and medical history,"X120113.Level of difficultly depression has made to do work, take care of things at home, or get along with other people",11960,0.269873270373345,0.0690877414593414,0.134461297113036,0.405285243633654,9.4260012413246e-05
PLA2G15,Phospholipase A2 group XV,Lifestyle factors,X1269.Exposure to tobacco smoke at home,46358,0.184619405853015,0.0669060608185119,0.0534835266487315,0.315755285057298,0.00579334562996614
PLA2G15,Phospholipase A2 group XV,Lifestyle factors,X1279.Exposure to tobacco smoke outside home,43252,0.0463073932420247,0.0413077406305239,-0.0346557783938021,0.127270564877852,0.262279497612303
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X1289.Cooked vegetable intake,49752,-0.21191096248734,0.0289435485882766,-0.268640317720362,-0.155181607254318,2.48862645024875e-13
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X1299.Salad  or  raw vegetable intake,48393,-0.324751748020209,0.0306808001220627,-0.384886116259452,-0.264617379780966,3.74203590899655e-26
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X1309.Fresh fruit intake,49644,-0.237039039604628,0.0303803236554288,-0.296584473969268,-0.177493605239987,6.19285100063266e-15
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X1319.Dried fruit intake,46892,-0.29418716091555,0.0315012307087724,-0.355929573104744,-0.232444748726356,1.01449031384307e-20
PLA2G15,Phospholipase A2 group XV,Health and medical history,X134.Number of self-reported cancers,51662,0.219988117155644,0.0536399156731899,0.114853882436192,0.325122351875096,4.11638787683578e-05
PLA2G15,Phospholipase A2 group XV,Health and medical history,X135.Number of self-reported non-cancer illnesses,51663,0.449339243121919,0.0291673211222012,0.392171293722404,0.506507192521433,1.97507678993655e-53
PLA2G15,Phospholipase A2 group XV,Health and medical history,"X136.Number of operations, self-reported",51663,0.107018377692458,0.0283404385840329,0.0514711180677535,0.162565637317162,0.000159435189834924
PLA2G15,Phospholipase A2 group XV,Health and medical history,X137.Number of treatments or medications taken,51663,0.48475950132882,0.0285161066723534,0.428867932251007,0.540651070406633,1.24245300171724e-64
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X1438.Bread intake,50161,0.00352465820022807,0.00139343903522668,0.000793517691183777,0.00625579870927236,0.0114266253424704
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X1458.Cereal intake,49043,-0.160321896126531,0.0288253944929736,-0.216819669332759,-0.103824122920303,2.6835160235147e-08
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X1488.Tea intake,49863,-0.00504534388751424,0.00133576943705065,-0.00766345198413352,-0.00242723579089496,0.000158844905685108
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X1498.Coffee intake,47609,-0.089601083934765,0.0289550179561363,-0.146352919128792,-0.0328492487407378,0.00197264232990467
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X1528.Water intake,47762,-0.0821905256369218,0.0292841493166718,-0.139587458297599,-0.024793592976245,0.00500789812093749
PLA2G15,Phospholipase A2 group XV,Lifestyle factors,X1568.Average weekly red wine intake,35170,-0.275944425591475,0.033671859103751,-0.341941269434827,-0.209947581748123,2.58769868210965e-16
PLA2G15,Phospholipase A2 group XV,Lifestyle factors,X1578.Average weekly champagne plus white wine intake,35165,-0.119619972622279,0.0345250284175769,-0.187289028320729,-0.0519509169238279,0.000531392656910956
PLA2G15,Phospholipase A2 group XV,Lifestyle factors,X1588.Average weekly beer plus cider intake,35260,0.192452200859577,0.0380411895137589,0.117891469412609,0.267012932306544,4.23467752496685e-07
PLA2G15,Phospholipase A2 group XV,Lifestyle factors,X1598.Average weekly spirits intake,35117,0.069031366716601,0.0368626894220144,-0.00321950455054723,0.141282237983749,0.0611233458452182
PLA2G15,Phospholipase A2 group XV,Lifestyle factors,X1608.Average weekly fortified wine intake,35237,0.0261400404216813,0.06140527041908,-0.0942142895997155,0.146494370443078,0.670331237278772
PLA2G15,Phospholipase A2 group XV,Lifestyle factors,X1737.Childhood sunburn occasions,38750,-0.0236272568474836,0.0340161105679399,-0.0902988335606457,0.0430443198656785,0.487316325153606
PLA2G15,Phospholipase A2 group XV,Health and medical history,X1807.Father's age at death,38073,-0.00650894131724678,0.00155364641481428,-0.00955408829028277,-0.00346379434421079,2.80247196680156e-05
PLA2G15,Phospholipase A2 group XV,Health and medical history,X1845.Mother's age,19643,-0.0106762119847582,0.00345566357127283,-0.017449312584453,-0.00390311138506347,0.00200785721310467
PLA2G15,Phospholipase A2 group XV,Health and medical history,X1873.Number of full brothers,50737,0.0319991916710245,0.0277916580903777,-0.0224724581861158,0.0864708415281648,0.249574967835577
PLA2G15,Phospholipase A2 group XV,Health and medical history,X1883.Number of full sisters,50746,0.0535617195460839,0.0278218192475835,-0.00096904617917988,0.108092485271348,0.0542137328535027
PLA2G15,Phospholipase A2 group XV,Physical measures,X20015.Sitting height,51257,-0.00145734097751189,0.00175934500715467,-0.00490565719153504,0.00199097523651126,0.407480181456508
PLA2G15,Phospholipase A2 group XV,Cognitive function,X20016.Fluid intelligence score,16570,-0.166179437360399,0.0459393139516251,-0.256220492705584,-0.0761383820152135,0.000298499072989248
PLA2G15,Phospholipase A2 group XV,Cognitive function,X20018.Prospective memory result,17263,0.239993579465711,0.0603457172987552,0.121715973560151,0.358271185371271,7.00814942034378e-05
PLA2G15,Phospholipase A2 group XV,Physical measures,X20019.Speech-reception-threshold (SRT) estimate (left),16354,0.006935908893624,0.00243157418447452,0.00217002349205395,0.0117017942951941,0.00434400404712314
PLA2G15,Phospholipase A2 group XV,Physical measures,X20021.Speech-reception-threshold (SRT) estimate (right),16330,0.00738659406319144,0.00243130383205049,0.00262123855237248,0.0121519495740104,0.00238435110443331
PLA2G15,Phospholipase A2 group XV,Cognitive function,X20023.Mean time to correctly identify matches,51044,0.00781148899336606,0.00141205363149856,0.00504386387562888,0.0105791141111032,3.18138745759646e-08
PLA2G15,Phospholipase A2 group XV,Health and medical history,X20107#1.Illnesses of father_Heart disease,44934,0.00185275193183901,0.00299844149705384,-0.00402419340238653,0.00772969726606454,0.536641108943839
PLA2G15,Phospholipase A2 group XV,Health and medical history,X20107#10.Illnesses of father_Alzheimer's disease or dementia,44060,-0.00607024361364851,0.00660291144919272,-0.0190119500540662,0.00687146282676922,0.357928893872395
PLA2G15,Phospholipase A2 group XV,Health and medical history,X20107#11.Illnesses of father_Parkinson's disease,43988,0.00267854783150765,0.00886737095759962,-0.0147014992453876,0.0200585949084029,0.762601755854926
PLA2G15,Phospholipase A2 group XV,Health and medical history,X20107#12.Illnesses of father_Severe depression,44030,-0.0106886401695338,0.007470750779441,-0.0253313116972381,0.00395403135817061,0.152514215446708
PLA2G15,Phospholipase A2 group XV,Health and medical history,X20107#13.Illnesses of father_Prostate cancer,44055,-0.00547305922579578,0.00534242619315505,-0.0159442145643797,0.00499809611278811,0.305627455988321
PLA2G15,Phospholipase A2 group XV,Health and medical history,X20107#2.Illnesses of father_Stroke,44399,-0.00338711491271552,0.0038681588987935,-0.0109687063543508,0.00419447652891974,0.381230475567927
PLA2G15,Phospholipase A2 group XV,Health and medical history,X20107#3.Illnesses of father_Lung cancer,44276,0.00448878758524067,0.00486867188516009,-0.0050538093096731,0.0140313844801544,0.356547303089462
PLA2G15,Phospholipase A2 group XV,Health and medical history,X20107#4.Illnesses of father_Bowel cancer,44077,0.0154850436374932,0.0060834528045281,0.00356147614061817,0.0274086111343683,0.0109174937840725
PLA2G15,Phospholipase A2 group XV,Health and medical history,X20107#6.Illnesses of father_Chronic bronchitis or emphysema,44357,0.0202864992760171,0.00446392292410866,0.0115372103447642,0.0290357882072701,5.51991446947122e-06
PLA2G15,Phospholipase A2 group XV,Health and medical history,X20107#8.Illnesses of father_High blood pressure,44500,-0.000228644569801865,0.00336279521877877,-0.00681972319860825,0.00636243405900452,0.945791977430372
PLA2G15,Phospholipase A2 group XV,Health and medical history,X20107#9.Illnesses of father_Diabetes,44227,0.0144251766493371,0.00465365771299816,0.00530400753186074,0.0235463457668135,0.00193805485457622
PLA2G15,Phospholipase A2 group XV,Health and medical history,X20110#1.Illnesses of mother_Heart disease,47123,-1.74711280015696e-05,0.00343119936082606,-0.00674262187522064,0.0067076796192175,0.995937336303652
PLA2G15,Phospholipase A2 group XV,Health and medical history,X20110#10.Illnesses of mother_Alzheimer's disease or dementia,46831,0.00343439994460491,0.00491914503642669,-0.0062071243267914,0.0130759242160012,0.485074295336226
PLA2G15,Phospholipase A2 group XV,Health and medical history,X20110#11.Illnesses of mother_Parkinson's disease,46686,0.00243640614155255,0.0107048638272133,-0.0185451269597855,0.0234179392428906,0.819959732351178
PLA2G15,Phospholipase A2 group XV,Health and medical history,X20110#12.Illnesses of mother_Severe depression,46757,0.00426869506663449,0.0055082094322079,-0.00652739542049299,0.015064785553762,0.438361521325508
PLA2G15,Phospholipase A2 group XV,Health and medical history,X20110#2.Illnesses of mother_Stroke,46998,0.00228751183552287,0.00391181606370781,-0.00537964764934443,0.00995467132039018,0.558705331963273
PLA2G15,Phospholipase A2 group XV,Health and medical history,X20110#3.Illnesses of mother_Lung cancer,46787,0.0196657078579171,0.00689711528756163,0.00614736189429628,0.0331840538215379,0.00435606588713625
PLA2G15,Phospholipase A2 group XV,Health and medical history,X20110#4.Illnesses of mother_Bowel cancer,46748,0.0056331937520581,0.0062030925110451,-0.0065248675695903,0.0177912550737065,0.363815983435284
PLA2G15,Phospholipase A2 group XV,Health and medical history,X20110#5.Illnesses of mother_Breast cancer,46787,-0.00374793716877924,0.00504768092207842,-0.0136413917760529,0.00614551743849446,0.457784090944172
PLA2G15,Phospholipase A2 group XV,Health and medical history,X20110#6.Illnesses of mother_Chronic bronchitis or emphysema,46840,0.0192747490078542,0.00580540382009582,0.00789615752046638,0.030653340495242,0.000900412674072045
PLA2G15,Phospholipase A2 group XV,Health and medical history,X20110#8.Illnesses of mother_High blood pressure,47199,-0.00572403321126016,0.00297526650935226,-0.0115555555695906,0.000107489147070265,0.0543765839524649
PLA2G15,Phospholipase A2 group XV,Health and medical history,X20110#9.Illnesses of mother_Diabetes,46902,0.017214703242026,0.00458262204794977,0.00823276402804441,0.0261966424560075,0.000172502096600091
PLA2G15,Phospholipase A2 group XV,Health and medical history,X20111#1.Illnesses of siblings_Heart disease,40419,0.00633771539010292,0.00480848495113879,-0.00308691511412911,0.015762345894335,0.187501915046444
PLA2G15,Phospholipase A2 group XV,Health and medical history,X20111#10.Illnesses of siblings_Alzheimer's disease or dementia,40132,-0.00137640615933233,0.0190450169463319,-0.0387046393741428,0.0359518270554782,0.942386446990559
PLA2G15,Phospholipase A2 group XV,Health and medical history,X20111#11.Illnesses of siblings_Parkinson's disease,40120,0.00105507098678757,0.0193953081273732,-0.0369597329428639,0.039069874916439,0.956618137206398
PLA2G15,Phospholipase A2 group XV,Health and medical history,X20111#12.Illnesses of siblings_Severe depression,40242,0.00458424129464892,0.00567942531287227,-0.00654743231858072,0.0157159149078786,0.419575392096622
PLA2G15,Phospholipase A2 group XV,Health and medical history,X20111#13.Illnesses of siblings_Prostate cancer,40152,-0.00167318311382855,0.0112063482068128,-0.0236376255991816,0.0202912593715245,0.881312361647767
PLA2G15,Phospholipase A2 group XV,Health and medical history,X20111#2.Illnesses of siblings_Stroke,40202,0.0159882513759534,0.0081257909103149,6.17011917362319e-05,0.0319148015601707,0.0491217226953913
PLA2G15,Phospholipase A2 group XV,Health and medical history,X20111#3.Illnesses of siblings_Lung cancer,40153,0.0130096341714558,0.00962900706560458,-0.00586321967712923,0.0318824880200407,0.176674917813674
PLA2G15,Phospholipase A2 group XV,Health and medical history,X20111#4.Illnesses of siblings_Bowel cancer,40156,0.0193291423891294,0.00932257589820399,0.00105689362864955,0.0376013911496092,0.0381442895130687
PLA2G15,Phospholipase A2 group XV,Health and medical history,X20111#5.Illnesses of siblings_Breast cancer,40179,0.00863713484356538,0.00707876728520275,-0.00523724903543202,0.0225115187225628,0.222416415638275
PLA2G15,Phospholipase A2 group XV,Health and medical history,X20111#6.Illnesses of siblings_Chronic bronchitis or emphysema,40197,0.0125347420135041,0.00873857840731856,-0.00459287166484031,0.0296623556918484,0.151461845259544
PLA2G15,Phospholipase A2 group XV,Health and medical history,X20111#8.Illnesses of siblings_High blood pressure,40558,-0.000439851915926038,0.00359345705140587,-0.00748302773668154,0.00660332390482947,0.902580030289019
PLA2G15,Phospholipase A2 group XV,Health and medical history,X20111#9.Illnesses of siblings_Diabetes,40342,0.0310586515792082,0.00509972360715829,0.0210631933091779,0.0410541098492384,1.13742838318044e-09
PLA2G15,Phospholipase A2 group XV,Mental health,X20127.Neuroticism score,41069,0.131748114027055,0.0292615998656999,0.0743953782902836,0.189100849763827,6.73676078560538e-06
PLA2G15,Phospholipase A2 group XV,Cognitive function,X20128.Number of fluid intelligence questions attempted within time limit,16570,0.00305916114353867,0.0464278375175379,-0.0879394003908356,0.0940577226779129,0.94746566784973
PLA2G15,Phospholipase A2 group XV,Lifestyle factors,X20161.Pack years of smoking,15734,0.034398622479719,0.00265739853061175,0.02919012135972,0.0396071235997181,3.95447659174398e-38
PLA2G15,Phospholipase A2 group XV,Lifestyle factors,X20162.Pack years adult smoking as proportion of life span exposed to smoking,15734,0.0348545812731996,0.00262083661099023,0.0297177415156588,0.0399914210307405,3.86364903933268e-40
PLA2G15,Phospholipase A2 group XV,Cognitive function,X20191.Fluid intelligence score,12776,-0.00616577970075425,0.0539545642649559,-0.111916725660068,0.0995851662585594,0.909019808669062
PLA2G15,Phospholipase A2 group XV,Cognitive function,X20192.Number of fluid intelligence questions attempted within time limit,12777,0.0403061222553491,0.0550040377255516,-0.0675017916867321,0.14811403619743,0.463703169357008
PLA2G15,Phospholipase A2 group XV,Cognitive function,X20240.Maximum digits remembered correctly,11477,-0.0299988471532547,0.0580595995075376,-0.143795662188028,0.083797967881519,0.605382159636521
PLA2G15,Phospholipase A2 group XV,Physical measures,X20255.Spirometry QC measure,38448,0.0112057818516348,0.0371155598789309,-0.0615407155110697,0.0839522792143393,0.762717722092416
PLA2G15,Phospholipase A2 group XV,Eye measures,X20261.avMSE,11323,-0.00110171778332804,0.00286790882429682,-0.0067228190789498,0.00451938351229372,0.700871755634755
PLA2G15,Phospholipase A2 group XV,Eye measures,X20262.Myopia diagnosis,11323,-0.0266581147833711,0.0703306768852092,-0.164506241478381,0.111190011911639,0.704665540940316
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X20280.Glucose-lactate,29495,0.0291659422507475,0.00177461002802604,0.0256877065958164,0.0326441779056785,1.99177858977741e-60
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X20281.Spectrometer-corrected alanine,29556,0.0287516940977972,0.00178228025227745,0.0252584248033334,0.032244963392261,2.70051530488379e-58
PLA2G15,Phospholipase A2 group XV,Mental health,X20544#11.Mental health problems ever diagnosed by a professional_Depression,16108,0.000112183641158318,0.00945756144929925,-0.0184246367994682,0.0186490040817849,0.990536027046585
PLA2G15,Phospholipase A2 group XV,Mental health,X20544#6.Mental health problems ever diagnosed by a professional_Panic attacks,16105,0.00315478237459157,0.0185989871995817,-0.0332992325365886,0.0396087972857717,0.865310187713118
PLA2G15,Phospholipase A2 group XV,Mental health,X20546#1.Substances taken for depression_Unprescribed medication (more than once),16104,-0.0111685230444137,0.0228859175548845,-0.0560249214519872,0.0336878753631599,0.625550447038379
PLA2G15,Phospholipase A2 group XV,Mental health,X20546#3.Substances taken for depression_Medication prescribed to you (for at least two weeks),16104,0.00158566322682713,0.00897017615836984,-0.0159958820435778,0.019167208497232,0.859690825091572
PLA2G15,Phospholipase A2 group XV,Mental health,X20546#4.Substances taken for depression_Drugs or alcohol (more than once),16104,0.00160445854290852,0.015648861000556,-0.0290673090181813,0.0322762261039984,0.918338252021197
PLA2G15,Phospholipase A2 group XV,Mental health,X20548#1.Manifestations of mania or irritability_I was more talkative than usual,16114,0.012581028038601,0.0200252001206845,-0.0266683641979407,0.0518304202751427,0.529842679374194
PLA2G15,Phospholipase A2 group XV,Mental health,X20548#2.Manifestations of mania or irritability_I was more restless than usual,16114,0.0136891121822665,0.0129792715831996,-0.0117502601208046,0.0391284844853377,0.291582804295604
PLA2G15,Phospholipase A2 group XV,Mental health,X20548#3.Manifestations of mania or irritability_My thoughts were racing,16114,0.0145961542846629,0.014572467826472,-0.0139658826552222,0.0431581912245481,0.316539589878616
PLA2G15,Phospholipase A2 group XV,Mental health,X20548#5.Manifestations of mania or irritability_I needed less sleep than usual,16114,0.00117529463838738,0.0226043044301507,-0.0431291420447079,0.0454797313214827,0.958533892508734
PLA2G15,Phospholipase A2 group XV,Mental health,X20548#6.Manifestations of mania or irritability_I was more creative or had more ideas than usual,16114,0.0209058669479985,0.0262699092009213,-0.0305831550858071,0.0723948889818042,0.426153978889403
PLA2G15,Phospholipase A2 group XV,Mental health,X20548#7.Manifestations of mania or irritability_I was easily distracted,16114,0.0341769750137919,0.0152191642648551,0.00434741305467592,0.0640065369729078,0.0247396963101184
PLA2G15,Phospholipase A2 group XV,Mental health,X20548#8.Manifestations of mania or irritability_I was more confident than usual,16114,0.0457923558997922,0.0258814858002606,-0.00493535626871845,0.0965200680683029,0.0768611842227042
PLA2G15,Phospholipase A2 group XV,Mental health,X20548#9.Manifestations of mania or irritability_I was more active than usual,16114,0.000112143770215225,0.019319102829741,-0.0377532977760771,0.0379775853165076,0.99536852763237
PLA2G15,Phospholipase A2 group XV,Mental health,X20549#1.Substances taken for anxiety_Unprescribed medication (more than once),16116,0.0240864374017173,0.0260588705436767,-0.026988948863889,0.0751618236673236,0.355339532448678
PLA2G15,Phospholipase A2 group XV,Mental health,X20549#3.Substances taken for anxiety_Medication prescribed to you (for at least two weeks),16116,0.0201785216293761,0.0119922094707174,-0.00332620893322995,0.0436832521919821,0.0924649941970683
PLA2G15,Phospholipase A2 group XV,Mental health,X20549#4.Substances taken for anxiety_Drugs or alcohol (more than once),16116,-0.0259336946508264,0.0180841291422484,-0.0613785877696333,0.00951119846798059,0.151575058504731
PLA2G15,Phospholipase A2 group XV,Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,16118,0.0234673815125799,0.0302590816862226,-0.0358404185924164,0.0827751816175761,0.438027082829289
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20600.Liking for adding salt to foods,18699,0.0540984117978057,0.0451448784099244,-0.0343855498856461,0.142582373481258,0.230804212052887
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20601.Liking for aniseed,18699,0.0368260783706355,0.0453668807341308,-0.0520930078682609,0.125745164609532,0.416951604857504
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20602.Liking for apple juice,18699,0.0737312405025045,0.0452545853491423,-0.0149677467818144,0.162430227786823,0.103276002097266
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20603.Liking for apples,18699,-0.120679149831641,0.0463205171726879,-0.211467363490109,-0.0298909361731725,0.00918648556745052
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20604.Liking for asparagus,18699,-0.201554599282219,0.0460667417955546,-0.291845413201506,-0.111263785362932,1.21937549549261e-05
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20605.Liking for aubergine,18699,-0.212588823691674,0.045249057433666,-0.301276976261659,-0.123900671121689,2.64342387686404e-06
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20606.Liking for avocados,18699,-0.163703832678169,0.0459076851568684,-0.253682895585631,-0.0737247697707071,0.000363466879489037
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20607.Liking for bacon,18699,-0.0827622018091108,0.0458323980512672,-0.172593701989595,0.00706929837137285,0.0709723032636565
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20608.Liking for baked or steamed fish,18699,-0.215604915191435,0.0460541802349751,-0.305871108451986,-0.125338721930884,2.86715389358357e-06
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20609.Liking for bananas,18699,0.035226048861255,0.0465141403113681,-0.0559416661490266,0.126393763871537,0.448868239553729
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20610.Liking for barbequed or grilled meat,18699,-0.189548894286541,0.0459356758410411,-0.279582818934982,-0.0995149696381009,3.70086120334041e-05
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20611.Liking for beef steak,18699,-0.192022391822034,0.0455358650660318,-0.281272687351457,-0.102772096292612,2.48796512601718e-05
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20612.Liking for beetroot,18699,-0.0923950918243939,0.0461956597347462,-0.182938584904496,-0.00185159874429139,0.04550590095134
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20613.Liking for bell pepper,18699,-0.0128829161318757,0.0457800191693854,-0.102611753703871,0.0768459214401196,0.778399721088835
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20614.Liking for bicycling,18699,-0.280997612990007,0.0452074462056724,-0.369604207553125,-0.192391018426889,5.21670495474312e-10
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20615.Liking for biscuits,18699,0.168194223957955,0.0457775978729761,0.0784701321269221,0.257918315788988,0.000239300090966857
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20616.Liking for bitter foods,18699,-0.0744559681385801,0.0452125646309694,-0.16307259481528,0.0141606585381198,0.0996163647749842
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20617.Liking for bitter or ale,18699,-0.163302731710623,0.0464386099123699,-0.254322407138868,-0.0722830562823783,0.000438265478775877
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20618.Liking for black olives,18699,-0.201148850047333,0.0457755120656942,-0.290868853696093,-0.111428846398572,1.11770492410337e-05
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20619.Liking for black pepper,18699,-0.0148695325772114,0.0458714798591539,-0.104777633101153,0.0750385679467302,0.745823278976295
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20620.Liking for blue cheese,18699,-0.10467296877536,0.0454204975911819,-0.193697144054077,-0.0156487934966434,0.0212037405252429
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20621.Liking for bolognese sauce,18699,-0.0490525197075412,0.0459464651202612,-0.139107591343253,0.0410025519281707,0.285714060960246
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20622.Liking for broad beans,18699,-0.079344884887579,0.0454501152296622,-0.168427110737717,0.00973734096255895,0.0808695218369585
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20623.Liking for broccoli,18699,-0.156691872985593,0.0469540605586862,-0.248721831680618,-0.0646619142905685,0.000848131206441225
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20624.Liking for brown rice,18699,-0.19119091486707,0.0458484572469365,-0.281053891071066,-0.101327938663075,3.05890528455519e-05
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20625.Liking for brussel sprouts,18699,-0.0737511090781362,0.0459976029289263,-0.163906410818832,0.0164041926625594,0.108870224530497
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20626.Liking for burgers (meat),18699,-0.107403148658174,0.0452426031556832,-0.196078650843313,-0.018727646473035,0.0176095424726634
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20627.Liking for burn of spicy foods,18699,-0.104445410720459,0.0454100248085104,-0.19344905934514,-0.0154417620957789,0.0214562554644525
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20628.Liking for butter on bread,18699,0.101541475552423,0.0458575770921514,0.0116606244518068,0.19142232665304,0.0268216134608828
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20629.Liking for butternut squash,18699,-0.252650980280324,0.0454877147232552,-0.341806901137905,-0.163495059422744,2.82577158397506e-08
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20630.Liking for cabbage,18699,-0.0389805028480401,0.0460157260921328,-0.12917132598862,0.0512103202925403,0.396943199785578
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20631.Liking for cake,18699,0.0306174850983131,0.0457321723060221,-0.0590175726214903,0.120252542818117,0.503187705379657
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20632.Liking for cake icing,18699,0.113045468341675,0.0452951060409116,0.0242670605014878,0.201823876181861,0.0125775104765972
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20633.Liking for capers,18699,-0.231357293648679,0.045274540202301,-0.320095392445188,-0.142619194852169,3.2516699181484e-07
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20634.Liking for cauliflower,18699,-0.0232811008312902,0.0464302091131762,-0.114284310693116,0.0677221090305352,0.61608048657889
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20635.Liking for cereal or granola bar,18699,-0.0374490357942898,0.0452368541523853,-0.126113269932965,0.0512151983443855,0.407769712362234
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20636.Liking for cheesecake,18699,0.0064167125881172,0.0454415619351382,-0.0826487488047536,0.095482173980988,0.887707140435815
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20637.Liking for cherries,18699,-0.09110907299148,0.047803633050608,-0.184804193770672,0.00258604778771164,0.0566781683683964
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20638.Liking for chicken,18699,-0.183519126723349,0.0477243057368599,-0.277058765967594,-0.0899794874791032,0.000120754456158965
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20639.Liking for chilli pepper,18699,-0.0655542993841424,0.0454542211098368,-0.154644572759423,0.0235359739911376,0.149261354001276
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20640.Liking for chips or french fries,18699,0.125633651275011,0.0457743225081107,0.0359159791591138,0.215351323390908,0.00606367404006207
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20641.Liking for cigarette smoking,18699,-0.0274583184923462,0.0731868586505101,-0.170904561447346,0.115987924462654,0.707530123481119
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20642.Liking for cod,18699,-0.132783801798912,0.0468409373046416,-0.224592038916009,-0.0409755646818144,0.00459063292416828
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20643.Liking for coffee with sugar,18699,0.15332289434291,0.0495589048370884,0.056187440862217,0.250458347823603,0.00197935266118219
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20644.Liking for coffee without sugar,18699,-0.0730817922787455,0.046302304892488,-0.163834309868022,0.0176707253105309,0.1144994371219
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20645.Liking for coriander,18699,-0.127267738063914,0.0454971384862465,-0.216442129496957,-0.0380933466308705,0.00515893204642765
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20646.Liking for corn flakes,18699,0.241694743576961,0.0453421039117521,0.152824219909927,0.330565267243996,9.90962846047009e-08
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20647.Liking for cream,18699,0.0708337122075156,0.0454460570259321,-0.0182405595633114,0.159907983978343,0.119100274581393
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20648.Liking for croissant,18699,0.0229806120715979,0.0453197619575213,-0.0658461213651438,0.11180734550834,0.612106730774969
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20649.Liking for cucumber,18699,0.0173325211473382,0.0458990718607493,-0.0726296596997304,0.107294701994407,0.705715356924889
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20650.Liking for curry,18699,-0.0169778452829107,0.0461052274552806,-0.107344091095261,0.0733884005294393,0.712697549588715
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20651.Liking for dairy products,18699,0.0530919369886518,0.0460709364495963,-0.0372070984525568,0.143390972429861,0.249173365139989
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20652.Liking for dark chocolate,18699,-0.117783160538982,0.0460664799968607,-0.208073461332829,-0.0274928597451346,0.010571574832647
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20653.Liking for diet fizzy drinks,18699,0.148590998539261,0.0468944798432712,0.0566778180464498,0.240504179032073,0.00153408982935845
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20654.Liking for dried fruit,18699,-0.137427672616744,0.0456078066270216,-0.226818973605706,-0.0480363716277813,0.00258813270208
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20655.Liking for eggs,18699,-0.0992822475595848,0.046856596151851,-0.191121176017213,-0.00744331910195682,0.0341160403391371
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20656.Liking for exercising alone,18699,-0.234395536384404,0.0451397682761788,-0.322869482205715,-0.145921590563094,2.09483306126607e-07
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20657.Liking for exercising with others,18699,-0.210741618264358,0.0453153615063536,-0.299559726816811,-0.121923509711904,3.33308911959447e-06
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20658.Liking for extra virgin olive oil,18699,-0.150571367959457,0.0462287437696822,-0.241179705748034,-0.0599630301708801,0.00112759931875269
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20659.Liking for fatty foods,18699,-0.0193423085511906,0.0452840485917266,-0.108099043790975,0.0694144266885936,0.669287430052085
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20660.Liking for fresh tomatoes,18699,-0.0355840454364274,0.0486574543990468,-0.130952656058559,0.0597845651857043,0.464594450078571
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20661.Liking for fried chicken,18699,-0.0715086811605734,0.0452410123031986,-0.160181065274843,0.0171637029536959,0.113982732671418
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20662.Liking for fried or battered fish,18699,0.0304090769089147,0.0456691260138199,-0.0591024100781723,0.119920563896002,0.505511155842607
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20663.Liking for fruit,18699,-0.0418155506507044,0.0504322497373104,-0.140662760135833,0.057031658834424,0.407034048403089
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20664.Liking for garlic,18699,-0.0967142422137634,0.0463378375165225,-0.187536403746147,-0.00589208068137929,0.0368876628411444
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20665.Liking for gherkins,18699,-0.11125392041114,0.0451740702115315,-0.199795098025742,-0.0227127427965382,0.013795299202817
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20666.Liking for globe artichoke,18699,-0.124182669614217,0.0454162418109832,-0.213198503563744,-0.03516683566469,0.00625676316459115
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20667.Liking for goat's cheese,18699,-0.224651195433399,0.0455413561261572,-0.313912253440667,-0.135390137426131,8.17119536968873e-07
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20668.Liking for going to a cafe,18699,-0.0877644093869062,0.0461736245545353,-0.178264713513795,0.00273589473998308,0.057350451787021
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20669.Liking for going to the gym,18699,-0.238885330719428,0.0454030410860479,-0.327875291248081,-0.149895370190774,1.44510126636906e-07
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20670.Liking for going to the pub,18699,-0.151829268111299,0.0455028602957074,-0.241014874290885,-0.0626436619317123,0.00084945650446408
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20671.Liking for grapefruit,18699,-0.00985914154633511,0.0457702537841786,-0.0995688389633251,0.0798505558706549,0.829453923739894
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20672.Liking for green olives,18699,-0.194987484147694,0.0456603438176866,-0.284481758030359,-0.105493210265028,1.96095178754905e-05
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20673.Liking for haddock,18699,-0.192743567650348,0.0466989785050782,-0.284273565520301,-0.101213569780395,3.68541243049652e-05
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20674.Liking for ham,18699,-0.053829108993883,0.0456943210188401,-0.14338997819081,0.0357317602030435,0.238801157280168
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20675.Liking for hard cheese,18699,0.029398347295379,0.0462892339283322,-0.0613285512041521,0.12012524579491,0.525370205240502
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20676.Liking for herring,18699,-0.224732299920773,0.0451583475857683,-0.313242661188879,-0.136221938652667,6.53068613742799e-07
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20677.Liking for honey,18699,-0.125301598510658,0.0456365728658418,-0.214749281327708,-0.0358539156936081,0.00604507752294434
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20678.Liking for horseradish or wasabi,18699,-0.173905735815306,0.045373050754398,-0.262836915293926,-0.0849745563366857,0.000127109219012018
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20679.Liking for ice cream,18699,0.0358696325192367,0.0456678320043044,-0.0536393182091998,0.125378583247673,0.432201871091999
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20680.Liking for jam,18699,0.120883733338609,0.0455911996110926,0.0315249821008674,0.21024248457635,0.00802097010864724
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20681.Liking for kiwi fruit,18699,-0.0317241650046624,0.0460489903528435,-0.121980186096236,0.0585318560869108,0.49088087839599
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20682.Liking for lager,18699,-0.0806117123014662,0.0457836389394545,-0.170347644622797,0.0091242200198645,0.0783038586572783
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20683.Liking for lamb,18699,-0.247401793310789,0.0461467393938974,-0.337849402522828,-0.15695418409875,8.36537712886312e-08
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20684.Liking for lemons,18699,-0.0324678681093318,0.0459035796265456,-0.122438884177361,0.0575031479586976,0.479385287437631
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20685.Liking for lentils or beans,18699,-0.081424683855354,0.0457355631950531,-0.171066387717658,0.0082170200069501,0.0750371906867019
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20686.Liking for liver,18699,-0.201810942209366,0.0452748220382311,-0.290549593404299,-0.113072291014433,8.3417174737878e-06
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20687.Liking for mackerel,18699,-0.293819247439276,0.0455909353263224,-0.383177480678868,-0.204461014199684,1.18672722223739e-10
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20688.Liking for marzipan,18699,0.0571081736166992,0.0452579876867165,-0.0315974822492651,0.145813829482664,0.207023440835677
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20689.Liking for mayonnaise,18699,-0.0628694727029968,0.0457144161553889,-0.152469728367559,0.0267307829615654,0.169065553864479
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20690.Liking for melon,18699,0.0313580273954201,0.0468044384400473,-0.0603786719470726,0.123094726737913,0.502878963121174
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20691.Liking for milk chocolate,18699,0.0158894971814646,0.0458133339844903,-0.0739046374281365,0.105683631791066,0.728721985138506
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20692.Liking for mushrooms,18699,-0.0972988256410709,0.0471014062296108,-0.189617581851108,-0.00498006943103371,0.0388676661603276
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20694.Liking for orange juice,18699,0.189953043154614,0.0458182166023697,0.100149338613969,0.279756747695259,3.40127428372165e-05
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20695.Liking for oranges,18699,-0.0363477224405407,0.0460476345205745,-0.126601086100867,0.0539056412197854,0.429917210623034
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20696.Liking for pasta,18699,-0.0390528297542815,0.0459081633785074,-0.129032829976156,0.0509271704675931,0.394961995865584
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20697.Liking for pears,18699,0.135956139759265,0.046079669842812,0.0456399868673539,0.226272292651177,0.00317696815382965
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20698.Liking for pizza,18699,-0.00124014055283719,0.0455030054867032,-0.0904260313067755,0.0879457502011012,0.978257408334682
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20699.Liking for plain yogurt,18699,-0.214055165086036,0.0456791468697113,-0.303586292950671,-0.124524037221402,2.80480565093544e-06
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20700.Liking for plums,18699,0.00912047574806454,0.0463240218856012,-0.0816746071477138,0.0999155586438429,0.843920169602694
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20701.Liking for pollock,18699,-0.165842918771263,0.0451980794714279,-0.254431154535262,-0.0772546830072644,0.000243942491425173
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20702.Liking for pork chop,18699,-0.189294354337611,0.0454468117350103,-0.278370105338231,-0.10021860333699,3.12498291763607e-05
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20703.Liking for porridge,18699,-0.069998908190488,0.0461349303571563,-0.160423371690514,0.0204255553095384,0.129216754773502
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20704.Liking for potato crisps,18699,0.0984321857923955,0.045453335507982,0.00934364819675085,0.18752072338804,0.030357003504749
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20705.Liking for potatoes,18699,0.145163693284496,0.0465039808470925,0.0540158908241951,0.236311495744798,0.00180186733618621
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20706.Liking for prawns,18699,-0.139602716707557,0.046361867558977,-0.230471977123152,-0.0487334562919623,0.00260604874824609
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20707.Liking for raw carrots,18699,-0.119847855795929,0.0459449318935332,-0.209899922307254,-0.0297957892846038,0.00910095341499652
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20708.Liking for red meat,18699,-0.19984307389571,0.0455005473963544,-0.289024146792565,-0.110662000998856,1.12877084856864e-05
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20709.Liking for red wine,18699,-0.274658196345892,0.0459141022012723,-0.364649836660386,-0.184666556031399,2.24431254660227e-09
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20710.Liking for regular (non-diet) fizzy drinks,18699,0.16512402966094,0.0471782956216046,0.0726545702425949,0.257593489079285,0.000466342640568329
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20711.Liking for roast chicken,18699,-0.187161703477573,0.0478964658049715,-0.281038776455317,-0.0932846304998288,9.35342021447344e-05
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20712.Liking for salad dressing,18699,-0.0201254539141464,0.0457742089577142,-0.109842903471266,0.0695919956429735,0.660182685483669
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20713.Liking for salad leaves,18699,-0.161928339829501,0.0465394625064402,-0.253145686342124,-0.0707109933168783,0.000503726577781607
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20714.Liking for salami,18699,-0.150377862572368,0.0452458653413691,-0.239059758641451,-0.0616959665032842,0.00089043548641228
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20715.Liking for salmon,18699,-0.240873844253752,0.0476686075716096,-0.334304315094106,-0.147443373413397,4.38817364900552e-07
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20716.Liking for salty foods,18699,0.085983035172807,0.0450846808677887,-0.00238293932805886,0.174349009673673,0.0565171065827598
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20717.Liking for salty pretzels,18699,-0.00924559507814079,0.0454418527337775,-0.0983116264363447,0.0798204362800631,0.838777797394836
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20718.Liking for sardines,18699,-0.212946568274422,0.0454332820617164,-0.301995801115386,-0.123897335433457,2.79172426205786e-06
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20719.Liking for sausages (meat),18699,-0.089046456920463,0.0456039533542399,-0.178430205494773,0.00033729165384716,0.0508814668200541
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20720.Liking for savoury biscuits,18699,0.0397094836326612,0.0456849524138861,-0.0498330230985555,0.129251990363878,0.384747445268537
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20721.Liking for shellfish (other than prawns),18699,-0.225899833000024,0.0453037524753563,-0.314695187851722,-0.137104478148326,6.20859153808188e-07
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20722.Liking for skimmed milk,18699,-0.133290296067996,0.0454250228645543,-0.222323340882522,-0.0442572512534693,0.00334715917682663
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20723.Liking for smoked fish,18699,-0.186867100273272,0.045608259398885,-0.276259288695087,-0.0974749118514577,4.19904610395572e-05
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20724.Liking for soft cheese,18699,-0.0600044272234771,0.0455380175092751,-0.149258941541656,0.0292500870947022,0.18762774775495
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20725.Liking for soy sauce,18699,-0.0060078668303673,0.0456727196515666,-0.0955263973474379,0.0835106636867033,0.895348224414707
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20726.Liking for soya milk,18699,-0.102329032460645,0.0452472632729247,-0.191013668475577,-0.0136443964457125,0.0237365543364991
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20727.Liking for spicy foods,18699,-0.0763232035887685,0.045674166784878,-0.165844570487129,0.0131981633095924,0.0947312068561446
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20728.Liking for spinach,18699,-0.218358445331243,0.0461315443887839,-0.308776272333259,-0.127940618329227,2.2242271842854e-06
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20729.Liking for spirits,18699,-0.0401387945433561,0.0453148719865439,-0.128955943636982,0.0486783545502699,0.375750024408388
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20730.Liking for strawberries,18699,0.0355064038112069,0.0494307397653787,-0.0613778461289353,0.132390653751349,0.472577531644068
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20731.Liking for sweet coffee house drinks,18699,0.106917882799108,0.0463516329350111,0.0160686822464866,0.19776708335173,0.0210841594243132
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20732.Liking for sweet foods,18699,0.0957424130491887,0.0453211980642145,0.00691286484332823,0.184571961255049,0.034654208854929
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20733.Liking for taking the stairs,18699,-0.222414994770039,0.0465948238830089,-0.313740849580737,-0.131089139959342,1.82527520297461e-06
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20734.Liking for tea with sugar,18699,0.0936221697885951,0.0550088377016189,-0.014195152106578,0.201439491683768,0.0887817990121148
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20735.Liking for tea without sugar,18699,-0.14966580284855,0.0477676738553833,-0.243290443605102,-0.0560411620919992,0.00173177404559873
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20736.Liking for tomato ketchup,18699,0.0727358904048137,0.0453181272478355,-0.0160876390009439,0.161559419810571,0.108509274410066
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20737.Liking for tinned tuna,18699,-0.102546706226541,0.0458116458736405,-0.192337532138876,-0.0127558803142052,0.0252039882489426
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20738.Liking for turnip (white),18699,-0.0713561716043833,0.0453737265612991,-0.16028867566453,0.017576332455763,0.115821007219762
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20739.Liking for vegetables,18699,-0.0472765739078484,0.0501136998293487,-0.145499425573372,0.050946277757675,0.345495591806267
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20740.Liking for vinegar,18699,0.0212234946324434,0.0455775840708301,-0.0681085701463835,0.11055555941127,0.641466881181441
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20741.Liking for watching television,18699,0.0418354505655998,0.0458354593488197,-0.0480020497580868,0.131672950889286,0.361395749615456
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20742.Liking for whisky,18699,-0.0498329003323907,0.0467705121043473,-0.141503104056911,0.0418373033921301,0.286673946964492
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20743.Liking for white bread,18699,0.173280652983015,0.0452540771146836,0.0845826618382346,0.261978644127794,0.000129052777096569
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20744.Liking for white rice,18699,0.0141127547717639,0.0454859856596494,-0.0750397771211489,0.103265286664677,0.756362147291546
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20745.Liking for white wine,18699,-0.158854223590834,0.0454123081225689,-0.247862347511069,-0.069846099670599,0.000469774906310669
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20746.Liking for whole grain breakfast cereal,18699,-0.155641161407451,0.0458948941845817,-0.245595154009231,-0.065687168805671,0.000697182029198855
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20747.Liking for whole milk,18699,0.0560910235684141,0.045287558006239,-0.0326725901238144,0.144854637260643,0.215526791200706
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20748.Liking for wholemeal bread,18699,-0.127721977334466,0.0473452815934044,-0.220518729257538,-0.0349252254113929,0.00698891860924783
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20749.Liking for working up a sweat,18699,-0.283587344367511,0.0454551127990283,-0.372679365453606,-0.194495323281415,4.50299155184901e-10
PLA2G15,Phospholipase A2 group XV,Physical measures,X21001.Body mass index (BMI),51421,-0.0550236071274745,0.00580118140674902,-0.0663939226847026,-0.0436532915702464,2.5257088987042e-21
PLA2G15,Phospholipase A2 group XV,Physical measures,X21002.Weight,51460,-0.00820893372161128,0.00327028576949119,-0.014618693829814,-0.00179917361340855,0.0120707618077206
PLA2G15,Phospholipase A2 group XV,Physical measures,X21021.Pulse wave Arterial Stiffness index,17137,0.0161767312462356,0.00240152099671088,0.0114697500926823,0.0208837123997889,1.67944285774784e-11
PLA2G15,Phospholipase A2 group XV,Health and medical history,X21025.Frequency of discomfort or pain in abdomen in last 3 months,17872,0.152300861900523,0.0485181053889538,0.0572053753381735,0.247396348462873,0.00169771383734006
PLA2G15,Phospholipase A2 group XV,Health and medical history,X21033.Frequency of hard or lumpy stools in the last 3 months,17890,0.00904188958270359,0.0501070384522244,-0.0891679057836563,0.107251684949063,0.856800183031724
PLA2G15,Phospholipase A2 group XV,Health and medical history,X21034.Frequency of loose or mushy or watery stools in the last 3 months,17892,-0.0839781735621804,0.0493926677854104,-0.180787802421585,0.012831455297224,0.0891078160203819
PLA2G15,Phospholipase A2 group XV,Health and medical history,X21040.Satisfaction with bowel habits,17813,0.0821197698066513,0.0459259234727854,-0.00789504020000817,0.172134579813311,0.0737782022157418
PLA2G15,Phospholipase A2 group XV,Health and medical history,X21041.Degree to which abdominal pain or discomfort or altered bowel habits affect or interfere with life in general,17794,0.156098219426077,0.0490612270089543,0.0599382144885264,0.252258224363627,0.00146664015751528
PLA2G15,Phospholipase A2 group XV,Health and medical history,X21042.Greatest number of times bowels opened per day,17804,0.0511611142752543,0.0494239702691707,-0.0457098674523203,0.148032096002829,0.300613961970179
PLA2G15,Phospholipase A2 group XV,Health and medical history,X21043.Least number of times bowels opened per week,17679,-0.0380609848004617,0.049219194399481,-0.134530605823444,0.0584086362225211,0.439357827115256
PLA2G15,Phospholipase A2 group XV,Health and medical history,X21044.Average number of times bowels opened per day,17741,0.225048705338012,0.0553838566892903,0.116496346227003,0.333601064449021,4.85641804312426e-05
PLA2G15,Phospholipase A2 group XV,Health and medical history,X21048.Degree bothered by back pain in the past 3 months,17901,-0.0908637988631274,0.0499727100392556,-0.188810310540068,0.00708271281381351,0.0690398407925969
PLA2G15,Phospholipase A2 group XV,Health and medical history,X21049.Degree bothered by pain in arms or legs or joints in the past 3 months,17891,-0.0752325487111031,0.0500226904451578,-0.173277021983612,0.0228119245614062,0.132607154341353
PLA2G15,Phospholipase A2 group XV,Health and medical history,X21050.Degree bothered by menstrual cramps or other problems with period in the last 3 months,10057,0.145935825373516,0.0792927608817223,-0.00947798595466012,0.301349636701691,0.0657289789788447
PLA2G15,Phospholipase A2 group XV,Health and medical history,X21051.Degree bothered by headaches in the last 3 months,17896,-0.053095906047304,0.0546201088278294,-0.160151319349849,0.0539595072552416,0.331016699628397
PLA2G15,Phospholipase A2 group XV,Health and medical history,X21052.Degree bothered by chest pain in the last 3 months,17893,-0.080777092417829,0.0747730591202286,-0.227332288293477,0.0657781034578191,0.280024631384678
PLA2G15,Phospholipase A2 group XV,Health and medical history,X21053.Degree bothered by dizziness in the last 3 months,17894,-0.206438313709764,0.0587981394084098,-0.321682666950247,-0.0911939604692808,0.000447579927032771
PLA2G15,Phospholipase A2 group XV,Health and medical history,X21054.Degree bothered by fainting spells in the last 3 months,17892,-0.272856394819805,0.144871915924352,-0.556805350031535,0.0110925603919249,0.0596580724910661
PLA2G15,Phospholipase A2 group XV,Health and medical history,X21055.Degree bothered by feeling heart pound or race in the last 3 months,17900,-0.0639113099747798,0.057307744194896,-0.176234488596776,0.0484118686472165,0.26476689978726
PLA2G15,Phospholipase A2 group XV,Health and medical history,X21056.Degree bothered by shortness of breath in the last 3 months,17896,-0.26146495812938,0.0569028829435578,-0.372994608698753,-0.149935307560006,4.3584445843543e-06
PLA2G15,Phospholipase A2 group XV,Health and medical history,X21057.Degree bothered by pain or problems during intercourse in the last 3 months,17485,0.11794335032292,0.0519468567593706,0.0161275110745536,0.219759189571287,0.0231917052304167
PLA2G15,Phospholipase A2 group XV,Health and medical history,X21058.Degree bothered by urinary frequency or bladder irritability in the last 3 months,17890,-0.0915946246987826,0.0513937039259692,-0.192326284393682,0.00913703499611702,0.0747311638569759
PLA2G15,Phospholipase A2 group XV,Health and medical history,X21059.Degree bothered by nausea in the last 3 months,17897,-0.311460593148632,0.0742874347782801,-0.457063965314061,-0.165857220983203,2.77051145386799e-05
PLA2G15,Phospholipase A2 group XV,Health and medical history,X21060.Degree bothered by feeling tired all the time in the last 3 months,17900,-0.315739224112213,0.0501612807993308,-0.414055334478901,-0.217423113745524,3.15607983376883e-10
PLA2G15,Phospholipase A2 group XV,Health and medical history,X21061.Degree bothered by trouble sleeping in the last 3 months,17897,-0.0857456411947888,0.0500195627474109,-0.183783984179714,0.0122927017901365,0.0865015972638484
PLA2G15,Phospholipase A2 group XV,Working and living environment,X21100.Water hardness (USGS classification),51145,-0.0259432099433156,0.0280421323925773,-0.0809057894327671,0.0290193695461359,0.354891676145667
PLA2G15,Phospholipase A2 group XV,Lifestyle factors,X2139.Age first had sexual intercourse,44612,-0.00692004638543741,0.00149265356308371,-0.00984564736908149,-0.00399444540179333,3.56100544287151e-06
PLA2G15,Phospholipase A2 group XV,Health and medical history,X2149.Lifetime number of sexual partners,41384,-0.0300178939827626,0.0318889062085879,-0.0925201501515948,0.0324843621860697,0.346542717555069
PLA2G15,Phospholipase A2 group XV,Physical activities,X22032.IPAQ activity group,41360,-0.34799613449497,0.0313134921046728,-0.409370579020129,-0.286621689969812,1.18692014719722e-28
PLA2G15,Phospholipase A2 group XV,Physical activities,X22033.Summed days activity,42451,-0.015462197990447,0.00145385800084904,-0.0183117596721111,-0.0126126363087829,2.20445274640141e-26
PLA2G15,Phospholipase A2 group XV,Physical activities,X22034.Summed minutes activity,41360,-0.0156957292599426,0.00146631013281531,-0.0185696971202606,-0.0128217613996246,1.05392458148486e-26
PLA2G15,Phospholipase A2 group XV,Physical activities,X22037.MET minutes per week for walking,39603,-0.00876786853253417,0.00149333189313874,-0.0116947990430861,-0.00584093802198225,4.35712100596741e-09
PLA2G15,Phospholipase A2 group XV,Physical activities,X22038.MET minutes per week for moderate activity,41360,-0.011281609416796,0.00147017542554458,-0.0141631532508634,-0.00840006558272861,1.70830947209669e-14
PLA2G15,Phospholipase A2 group XV,Physical activities,X22039.MET minutes per week for vigorous activity,41360,-0.428674146808014,0.0314506276323911,-0.490317376967501,-0.367030916648527,3.27442359040447e-42
PLA2G15,Phospholipase A2 group XV,Physical activities,X22040.Summed MET minutes per week for all activity,39603,-0.0161753025178932,0.00149851153453925,-0.0191123851255901,-0.0132382199101963,3.99777170854986e-27
PLA2G15,Phospholipase A2 group XV,Eye measures,X2217.Age started wearing glasses or contact lenses,43910,-0.000888271936577918,0.0014570422084787,-0.00374407466519618,0.00196753079204034,0.542103134317589
PLA2G15,Phospholipase A2 group XV,Working and living environment,X22501.Year ended full time education,12576,-0.0165695177164114,0.00639163162091388,-0.0290971156934026,-0.00404191973942021,0.00954256987859748
PLA2G15,Phospholipase A2 group XV,Lifestyle factors,X22506.Tobacco smoking,12494,-0.0511190016931641,0.11710474315406,-0.280644298275122,0.178406294888794,0.662464323887019
PLA2G15,Phospholipase A2 group XV,Lifestyle factors,X2277.Frequency of solarium or sunlamp use,48273,-0.152228600589981,0.0739726715790307,-0.297215036884881,-0.00724216429508098,0.039604781080664
PLA2G15,Phospholipase A2 group XV,Physical measures,X23098.Weight,50582,-0.00775346074628171,0.00329069120387444,-0.0142032155058756,-0.00130370598668781,0.0184677628241613
PLA2G15,Phospholipase A2 group XV,Physical measures,X23099.Body fat percentage,50553,0.0329123968493545,0.00315371727448776,0.0267311109913585,0.0390936827073505,1.80134033260384e-25
PLA2G15,Phospholipase A2 group XV,Physical measures,X23100.Whole body fat mass,50502,0.0273693456349958,0.00304471329512552,0.0214017075765498,0.0333369836934419,2.5756251906502e-19
PLA2G15,Phospholipase A2 group XV,Physical measures,X23101.Whole body fat-free mass,50576,-0.0175668136356212,0.00275173071738586,-0.0229602058416975,-0.0121734214295449,1.74109549867384e-10
PLA2G15,Phospholipase A2 group XV,Physical measures,X23102.Whole body water mass,50582,-0.0176169716493584,0.00275537311053667,-0.0230175029460103,-0.0122164403527065,1.63349070959175e-10
PLA2G15,Phospholipase A2 group XV,Physical measures,X23104.Body mass index (BMI),50582,-0.0546102569540283,0.00582147612288499,-0.0660203501548829,-0.0432001637531737,6.80680987498237e-21
PLA2G15,Phospholipase A2 group XV,Physical measures,X23105.Basal metabolic rate,50580,-0.0182794543283777,0.00294436340357587,-0.0240504065993864,-0.0125085020573689,5.39801136300794e-10
PLA2G15,Phospholipase A2 group XV,Physical measures,X23106.Impedance of whole body,50576,0.0291134190403501,0.00224998878327638,0.0247034410251284,0.0335233970555718,3.10397564302594e-38
PLA2G15,Phospholipase A2 group XV,Physical measures,X23107.Impedance of leg (right),50579,0.0215381553467165,0.00183653961465322,0.0179385377019961,0.0251377729914368,1.01203747205399e-31
PLA2G15,Phospholipase A2 group XV,Physical measures,X23108.Impedance of leg (left),50578,0.0212560216070922,0.00182418251521875,0.0176806238772635,0.024831419336921,2.44792909418831e-31
PLA2G15,Phospholipase A2 group XV,Physical measures,X23109.Impedance of arm (right),50569,0.0245134880833302,0.0022416068747319,0.0201199386088557,0.0289070375578047,8.36153718189091e-28
PLA2G15,Phospholipase A2 group XV,Physical measures,X23110.Impedance of arm (left),50577,0.0247148577709651,0.002244356010505,0.0203159199903753,0.0291137955515549,3.60091396514591e-28
PLA2G15,Phospholipase A2 group XV,Physical measures,X23111.Leg fat percentage (right),50578,0.0362298465414593,0.00382203376624051,0.0287386603596279,0.0437210327232907,2.66882814024544e-21
PLA2G15,Phospholipase A2 group XV,Physical measures,X23112.Leg fat mass (right),50577,0.0334868584778621,0.00406214992156622,0.0255250446315923,0.0414486723241319,1.71033269669489e-16
PLA2G15,Phospholipase A2 group XV,Physical measures,X23113.Leg fat-free mass (right),50576,-0.015129333762637,0.00288023208628285,-0.0207745886517514,-0.00948407887352263,1.50395025520601e-07
PLA2G15,Phospholipase A2 group XV,Physical measures,X23114.Leg predicted mass (right),50575,-0.0147162681813019,0.00289489935339159,-0.0203902709139494,-0.00904226544865435,3.71829307710785e-07
PLA2G15,Phospholipase A2 group XV,Physical measures,X23115.Leg fat percentage (left),50572,0.0374344628694233,0.00398306969814644,0.0296276462610563,0.0452412794777904,5.76282245703931e-21
PLA2G15,Phospholipase A2 group XV,Physical measures,X23116.Leg fat mass (left),50572,0.0327127372648119,0.0042386030748518,0.0244050752381023,0.0410203992915214,1.2050783295782e-14
PLA2G15,Phospholipase A2 group XV,Physical measures,X23117.Leg fat-free mass (left),50569,-0.0130355398012612,0.00300790533198377,-0.0189310342519494,-0.00714004535057304,1.46866600123665e-05
PLA2G15,Phospholipase A2 group XV,Physical measures,X23118.Leg predicted mass (left),50568,-0.0131717194342928,0.00302347538470667,-0.0190977311883179,-0.00724570768026771,1.32428862236007e-05
PLA2G15,Phospholipase A2 group XV,Physical measures,X23119.Arm fat percentage (right),50568,0.0199110690359079,0.00350529806842371,0.0130406848217975,0.0267814532500184,1.35212048984756e-08
PLA2G15,Phospholipase A2 group XV,Physical measures,X23120.Arm fat mass (right),50563,0.00248163791694853,0.00347243932853383,-0.00432434316697777,0.00928761900087483,0.474818112639222
PLA2G15,Phospholipase A2 group XV,Physical measures,X23121.Arm fat-free mass (right),50564,-0.018115299832108,0.00277119434758249,-0.0235468407533697,-0.0126837589108463,6.33602577214672e-11
PLA2G15,Phospholipase A2 group XV,Physical measures,X23122.Arm predicted mass (right),50563,-0.0176568472779289,0.00277474345121529,-0.0230953444423108,-0.0122183501135469,1.98999726342121e-10
PLA2G15,Phospholipase A2 group XV,Physical measures,X23123.Arm fat percentage (left),50558,0.0232299534240688,0.00359348878121041,0.0161867154128964,0.0302731914352412,1.02586663243707e-10
PLA2G15,Phospholipase A2 group XV,Physical measures,X23124.Arm fat mass (left),50557,0.00226527730430267,0.00346555505296219,-0.00452721059950322,0.00905776520810856,0.513337090427141
PLA2G15,Phospholipase A2 group XV,Physical measures,X23125.Arm fat-free mass (left),50553,-0.02076905436781,0.00282392720076581,-0.0263039516813109,-0.015234157054309,1.94289863742171e-13
PLA2G15,Phospholipase A2 group XV,Physical measures,X23126.Arm predicted mass (left),50550,-0.0210011196171529,0.00283293277487196,-0.0265536678559019,-0.0154485713784038,1.25202217650936e-13
PLA2G15,Phospholipase A2 group XV,Physical measures,X23127.Trunk fat percentage,50546,0.0212764506106963,0.00226029967060256,0.0168462632563153,0.0257066379650773,5.0115836288957e-21
PLA2G15,Phospholipase A2 group XV,Physical measures,X23128.Trunk fat mass,50542,0.0226048856527113,0.00248770619113105,0.0177289815180944,0.0274807897873281,1.05735007311646e-19
PLA2G15,Phospholipase A2 group XV,Physical measures,X23129.Trunk fat-free mass,50535,-0.0171980006583661,0.00249403946446422,-0.022086318008716,-0.0123096833080162,5.42506951612347e-12
PLA2G15,Phospholipase A2 group XV,Physical measures,X23130.Trunk predicted mass,50530,-0.0170310339547056,0.0024954905056844,-0.021922195345847,-0.0121398725635642,8.90854902383764e-12
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23400.Total Cholesterol,29566,-0.0113969570364163,0.00180372415129102,-0.0149322563729467,-0.00786165769988589,2.67754419617597e-10
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23401.Total Cholesterol Minus HDL-C,29566,-0.00689449093303847,0.00174903267001776,-0.0103225949662733,-0.00346638689980365,8.10288022533412e-05
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,"X23402.Remnant Cholesterol (Non-HDL, Non-LDL -Cholesterol)",29566,0.000515996767902581,0.00175311936367338,-0.00292011718489724,0.0039521107207024,0.768507318678155
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23403.VLDL Cholesterol,29566,0.0101254535925263,0.0017569428457719,0.00668184561481334,0.0135690615702392,8.3398209917512e-09
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23404.Clinical LDL Cholesterol,29566,-0.0159092505829095,0.0017487207962359,-0.0193367433435319,-0.0124817578222872,9.79400030602053e-20
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23405.LDL Cholesterol,29566,-0.0134162334589883,0.00174441343388375,-0.0168352837894004,-0.00999718312857615,1.50552437103025e-14
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23406.HDL Cholesterol,29566,-0.0235384948338937,0.00202681088602488,-0.0275110441705024,-0.0195659454972849,4.10895406345525e-31
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23407.Total Triglycerides,29566,0.0330580978483604,0.00185141037068884,0.0294293335218102,0.0366868621749105,6.16999562119396e-71
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23408.Triglycerides in VLDL,29566,0.0277088910128032,0.0018688456896308,0.0240459534611268,0.0313718285644795,1.48338702972679e-49
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23409.Triglycerides in LDL,29566,0.0397989148466891,0.00178827972124546,0.036293886593048,0.0433039431003302,7.84849277774858e-109
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23410.Triglycerides in HDL,29566,0.0486427359950536,0.00177040888969419,0.045172734571253,0.0521127374188542,4.00301363101649e-164
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23411.Total Phospholipids in Lipoprotein Particles,29566,0.00607884444526526,0.00183146626717191,0.00248917056160831,0.0096685183289222,0.000904128668748639
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23412.Phospholipids in VLDL,29566,0.0198622745858517,0.00179485604269719,0.0163443567421652,0.0233801924295382,2.08055938752802e-28
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23413.Phospholipids in LDL,29566,-0.0116099833407289,0.00174110649540716,-0.0150225520717269,-0.00819741460973088,2.6358406238154e-11
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23414.Phospholipids in HDL,29566,0.00191769400429767,0.00195978710384077,-0.00192348871923024,0.00575887672782558,0.327824425870955
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23415.Total Esterified Cholesterol,29566,-0.0131666432161801,0.00181223856172633,-0.0167186307971637,-0.0096146556351965,3.81125752101048e-13
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23416.Cholesteryl Esters in VLDL,29566,0.00624861499597071,0.00174741509857953,0.00282368140275484,0.00967354858918659,0.000349556369679529
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23417.Cholesteryl Esters in LDL,29566,-0.0106553264595338,0.00174166085510842,-0.0140689817355463,-0.00724167118352132,9.59992816721635e-10
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23418.Cholesteryl Esters in HDL,29566,-0.0277646751360726,0.00201814788721805,-0.0317202449950199,-0.0238091052771252,6.22809829599239e-43
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23419.Total Free Cholesterol,29566,-0.00695033543837133,0.00178333443750002,-0.0104456709358714,-0.00345499994087128,9.74526140277991e-05
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23420.Free Cholesterol in VLDL,29566,0.0149341663285685,0.00177959789629727,0.0114461544518258,0.0184221782053111,4.99499536708571e-17
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23421.Free Cholesterol in LDL,29566,-0.0206917780710865,0.00175892770035239,-0.0241392763637772,-0.0172442797783958,7.05999364585719e-32
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23422.Free Cholesterol in HDL,29566,-0.00750098193000836,0.00203037275675482,-0.0114805125332478,-0.00352145132676892,0.000220815558575493
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23423.Total Lipids in Lipoprotein Particles,29566,0.00659943936370118,0.00176832790098147,0.0031335166777775,0.0100653620496249,0.000190304297468757
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23424.Total Lipids in VLDL,29566,0.0223965434072283,0.00181717190799643,0.0188348864675553,0.0259582003469013,8.0974307335702e-35
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23425.Total Lipids in LDL,29566,-0.00982545636741467,0.0017429610128463,-0.0132416599525934,-0.00640925278223592,1.74390455059698e-08
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23426.Total Lipids in HDL,29566,-0.00517799529048369,0.0019870161875176,-0.00907254701801819,-0.00128344356294919,0.00916751463528905
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23427.Total Concentration of Lipoprotein Particles,29566,-0.00988824953102367,0.00186295791104422,-0.0135396470366703,-0.00623685202537701,1.1174218070042e-07
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23428.Concentration of VLDL Particles,29566,0.0166906314693636,0.00176998544009806,0.0132214600067714,0.0201598029319558,4.39839325640084e-21
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23429.Concentration of LDL Particles,29566,-0.00893909887565865,0.00173924370423436,-0.012348016535958,-0.00553018121535929,2.77005566034224e-07
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23430.Concentration of HDL Particles,29566,-0.00996093562565526,0.00186966688226745,-0.0136254827148995,-0.00629638853641105,1.00217569720639e-07
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23431.Average Diameter for VLDL Particles,29566,0.0164561727858572,0.00194654653440571,0.0126409415784221,0.0202714039932924,2.94163746538241e-17
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23432.Average Diameter for LDL Particles,29566,-0.0336023287440111,0.0018117753122759,-0.0371534083560719,-0.0300512491319504,2.35788413051575e-76
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23433.Average Diameter for HDL Particles,29566,-0.0105529955476489,0.00208145459225365,-0.014632646548466,-0.0064733445468317,4.00194698687694e-07
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23434.Phosphoglycerides,29542,0.0104534741189064,0.00184243611370379,0.00684229933604692,0.0140646489017658,1.41032392276851e-08
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23435.Triglycerides to Phosphoglycerides ratio,29542,0.0360930269238776,0.00196453431008849,0.0322425396761041,0.039943514171651,5.73446205713505e-75
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23436.Total Cholines,29542,0.00542717001031293,0.00185958981808486,0.00178237396686661,0.00907196605375925,0.00352011258183508
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23437.Phosphatidylcholines,29542,0.00861150924991463,0.00186631256410027,0.00495353662427809,0.0122694818755512,3.96300150110114e-06
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23438.Sphingomyelins,29541,-0.00976767564203313,0.00187168162998064,-0.0134361716367952,-0.00609917964727107,1.81436415387863e-07
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23439.Apolipoprotein B,29566,-0.00507725468763058,0.00174185609254279,-0.00849129262901445,-0.00166321674624671,0.0035612301047882
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23440.Apolipoprotein A1,29566,-0.00299443589833933,0.00193394830924878,-0.00678497458446693,0.000796102787788273,0.12154788546909
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23441.Apolipoprotein B to Apolipoprotein A1 ratio,29566,-0.00322355032375129,0.00177914189884778,-0.00671066844549294,0.000263567797990366,0.070018473957792
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23442.Total Fatty Acids,29542,0.0182971557546661,0.00177031119800568,0.0148273458065749,0.0217669657027572,5.36761862445156e-25
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23443.Degree of Unsaturation,29542,-0.0767549460244659,0.00186460531962817,-0.0804095724509371,-0.0731003195979947,0
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23444.Omega-3 Fatty Acids,29542,-0.0303649665277667,0.00179945986231157,-0.0338919078578974,-0.026838025197636,1.37778479135711e-63
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23445.Omega-6 Fatty Acids,29542,-0.00627346018216862,0.00177513675459999,-0.00975272822118461,-0.00279419214315264,0.000409835620809328
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23446.Polyunsaturated Fatty Acids,29542,-0.0126581512566796,0.00178277730002545,-0.0161523947647294,-0.00916390774862968,1.27351483412764e-12
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23447.Monounsaturated Fatty Acids,29542,0.0305216926782017,0.00180967861746943,0.0269747225879616,0.0340686627684417,1.59366697077893e-63
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23448.Saturated Fatty Acids,29542,0.0312136637809678,0.00177262057563506,0.0277393274527231,0.0346880001092125,4.75973150549939e-69
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23449.Linoleic Acid,29542,-0.0027270457772204,0.00176893364195387,-0.00619415571544999,0.000740064161009195,0.123173613789923
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23450.Docosahexaenoic Acid,29542,-0.0427968263680134,0.0018425371687963,-0.0464081992188542,-0.0391854535171727,2.79072177368907e-118
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23451.Omega-3 Fatty Acids to Total Fatty Acids percentage,29542,-0.0490162899712105,0.00180109578468649,-0.052546437709196,-0.045486142233225,4.24474034163995e-161
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23452.Omega-6 Fatty Acids to Total Fatty Acids percentage,29542,-0.0492912729557749,0.00187557130471209,-0.0529673927130106,-0.0456151531985392,1.72168992037242e-150
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23453.Polyunsaturated Fatty Acids to Total Fatty Acids percentage,29542,-0.0705200036826414,0.00188988181058993,-0.0742241720313976,-0.0668158353338851,7.98083083906604e-298
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23454.Monounsaturated Fatty Acids to Total Fatty Acids percentage,29542,0.0489118550062082,0.00194937851510695,0.0450910731165986,0.0527326368958178,1.723580055784e-137
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23455.Saturated Fatty Acids to Total Fatty Acids percentage,29542,0.0612551315835928,0.00174494058649392,0.0578350480340648,0.0646752151331209,1.59718855806876e-264
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23456.Linoleic Acid to Total Fatty Acids percentage,29542,-0.0372131823967225,0.00188207960276937,-0.0409020584181504,-0.0335243063752945,1.86934040059478e-86
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23457.Docosahexaenoic Acid to Total Fatty Acids percentage,29542,-0.0550903142149538,0.00184079455291852,-0.0586982715386741,-0.0514823568912335,6.83260389035954e-194
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23458.Polyunsaturated Fatty Acids to Monounsaturated Fatty Acids ratio,29542,-0.0615412364143224,0.00193693061149611,-0.0653376204128548,-0.0577448524157901,7.26926809492554e-218
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23459.Omega-6 Fatty Acids to Omega-3 Fatty Acids ratio,29540,0.0316865008833047,0.00179474638276186,0.0281687979730914,0.0352042037935179,2.11387300855589e-69
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23460.Alanine,29556,0.023095769553401,0.00176777234503611,0.0196309357571303,0.0265606033496718,6.69928064480059e-39
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23461.Glutamine,29481,-0.0119010164287662,0.00175847315781487,-0.0153476238180834,-0.00845440903944909,1.33192076624589e-11
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23462.Glycine,29531,-0.00308828131784978,0.00186207109322395,-0.00673794066056872,0.000561378024869162,0.0972232693102835
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23463.Histidine,29528,-0.0113909491438127,0.00174659947886287,-0.0148142841223839,-0.0079676141652415,7.05969184560472e-11
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23464.Total Concentration of Branched-Chain Amino Acids (Leucine + Isoleucine + Valine),29544,-0.00330380424602924,0.0018522489004936,-0.0069342120909967,0.00032660359893822,0.0744872671431273
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23465.Isoleucine,29560,-0.00381343391535425,0.00180778229797334,-0.00735668721938199,-0.0002701806113265,0.0349137859862747
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23466.Leucine,29561,-0.0055940568026853,0.00184811668963684,-0.00921636551437351,-0.00197174809099709,0.00247291821494307
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23467.Valine,29544,-0.00126159367013608,0.00185578490144272,-0.00489893207696382,0.00237574473669165,0.496625825082281
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23468.Phenylalanine,29554,0.00701559747366782,0.0017682862172543,0.00354975648784939,0.0104814384594863,7.28153898992838e-05
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23469.Tyrosine,29532,0.0181793793117714,0.001795796838637,0.0146596175080429,0.0216991411154999,4.76743943831994e-24
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23470.Glucose,29512,0.0132971242604245,0.00177721957665078,0.00981377389018892,0.01678047463066,7.52488410557913e-14
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23471.Lactate,29513,0.0317862408202535,0.00175266351451664,0.0283510203318009,0.0352214613087061,4.14145819294957e-73
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23472.Pyruvate,29481,0.0146649915476681,0.00175627924225222,0.0112226842328538,0.0181072988624825,7.11956363981402e-17
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23473.Citrate,29562,0.0132563200121769,0.00178118268014286,0.00976520195909686,0.0167474380652569,1.01543570168091e-13
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23474.3-Hydroxybutyrate,29086,0.00474849943234931,0.00177913010827276,0.00126140442013471,0.00823559444456392,0.00761195376684773
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23475.Acetate,29540,-0.0175228550045965,0.00175647883196517,-0.0209655535152482,-0.0140801564939448,2.11164230221697e-23
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23476.Acetoacetate,29564,-0.00793909994659483,0.00176053279794051,-0.0113897442305582,-0.00448845566263143,6.5234233086253e-06
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23477.Acetone,29564,-0.017252064105827,0.0017556914222014,-0.0206932192933417,-0.0138109089183122,9.39430981060624e-23
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23478.Creatinine,28833,-0.00743988573774871,0.00208786692045343,-0.0115321049018374,-0.00334766657365999,0.000366686150813532
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23479.Albumin,29562,-0.0146572014315934,0.00177833484916178,-0.0181427377359505,-0.0111716651272363,1.76152045984738e-16
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23480.Glycoprotein Acetyls,29566,0.029636590043885,0.00186300705213476,0.0259850962217009,0.0332880838660692,9.60819516201763e-57
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23481.Concentration of Chylomicrons and Extremely Large VLDL Particles,29566,0.036989577079,0.0018699288691835,0.0333245164954003,0.0406546376625996,1.56890668257011e-86
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23482.Total Lipids in Chylomicrons and Extremely Large VLDL,29566,0.0360685378533042,0.00186579141968988,0.032411586670712,0.0397254890358963,9.47712943715932e-83
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23483.Phospholipids in Chylomicrons and Extremely Large VLDL,29566,0.0376242024416375,0.00187680446263322,0.0339456656948764,0.0413027391883986,8.36823905729417e-89
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23484.Cholesterol in Chylomicrons and Extremely Large VLDL,29566,0.0364299603466121,0.00185939460806366,0.0327855469148073,0.0400743737784168,6.22064438119393e-85
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23485.Cholesteryl Esters in Chylomicrons and Extremely Large VLDL,29566,0.0355904104193395,0.0018529231023682,0.0319586811386979,0.0392221396999812,1.0057213162016e-81
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23486.Free Cholesterol in Chylomicrons and Extremely Large VLDL,29566,0.0366503528281318,0.00186015642972234,0.033004446225876,0.0402962594303876,7.2624217584534e-86
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23487.Triglycerides in Chylomicrons and Extremely Large VLDL,29566,0.0341028601406876,0.00185887575180375,0.0304594636671522,0.0377462566142229,9.25697299102701e-75
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,29566,0.029893506731768,0.00188286698951545,0.0262030874323178,0.0335839260312183,1.57752079933616e-56
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23489.Total Lipids in Very Large VLDL,29566,0.0287650285689477,0.00188069058338516,0.0250788750255128,0.0324511821123826,1.31511437449209e-52
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23490.Phospholipids in Very Large VLDL,29566,0.0287739793601808,0.00186982733893299,0.0251091177758722,0.0324388409444895,3.14291334609012e-53
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23491.Cholesterol in Very Large VLDL,29566,0.0212250651801754,0.00183368988130902,0.0176310330128097,0.0248190973475411,6.42918492514075e-31
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23492.Cholesteryl Esters in Very Large VLDL,29566,0.0153978467450062,0.00181068312057338,0.0118489078286824,0.0189467856613301,1.91856630997783e-17
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23493.Free Cholesterol in Very Large VLDL,29566,0.026401748298993,0.00185535351793539,0.0227652554038397,0.0300382411941464,8.45389802510884e-46
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23494.Triglycerides in Very Large VLDL,29566,0.0308282371117,0.00189720659226418,0.0271097121908622,0.0345467620325378,4.08018183060618e-59
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23495.Concentration of Large VLDL Particles,29566,0.0239940114511976,0.00186263821023669,0.0203432405591337,0.0276447823432615,7.21393613793965e-38
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23496.Total Lipids in Large VLDL,29566,0.0207790049630434,0.00186034786203442,0.017132723153456,0.0244252867726309,6.57694020917845e-29
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23497.Phospholipids in Large VLDL,29566,0.0260218323508105,0.00186791862390434,0.022360711847958,0.029682952853663,5.66285717307208e-44
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23498.Cholesterol in Large VLDL,29566,0.0175976299193475,0.00182633379029524,0.0140180156903688,0.0211772441483262,6.09872364809226e-22
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23499.Cholesteryl Esters in Large VLDL,29566,0.0119722205443249,0.00179483485666384,0.00845434422526375,0.015490096863386,2.596498010176e-11
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23500.Free Cholesterol in Large VLDL,29566,0.0224835783206773,0.00186095766565215,0.0188361012959991,0.0261310553453555,1.58274454614009e-33
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23501.Triglycerides in Large VLDL,29566,0.0188774391046799,0.00186878792136409,0.0152146147788063,0.0225402634305535,5.95425615273994e-24
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23502.Concentration of Medium VLDL Particles,29566,0.00166238619529554,0.00175647861485985,-0.00178031188982978,0.00510508428042085,0.343936427220163
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23503.Total Lipids in Medium VLDL,29566,0.0056544994978017,0.0017710191409112,0.00218330198161576,0.00912569701398765,0.00141050936884114
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23504.Phospholipids in Medium VLDL,29566,0.00180530047398918,0.00175207139319424,-0.00162875945667152,0.00523936040464989,0.302839782245361
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23505.Cholesterol in Medium VLDL,29566,-0.0130046509143622,0.00174526364837809,-0.0164253676651832,-0.00958393416354111,9.48831076339776e-14
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23506.Cholesteryl Esters in Medium VLDL,29566,-0.020331055809314,0.00176014564764268,-0.0237809412786937,-0.0168811703399344,8.51946603200795e-31
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23507.Free Cholesterol in Medium VLDL,29566,-0.00313891780560902,0.00174510465340096,-0.0065593229262749,0.000281487315056865,0.0720765243417998
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23508.Triglycerides in Medium VLDL,29566,0.0165630943463504,0.00183577733364362,0.012964970772409,0.0201612179202919,1.94891694752355e-19
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23509.Concentration of Small VLDL Particles,29566,0.0166821049675416,0.00179174188923403,0.0131702908646429,0.0201939190704403,1.35697896953299e-20
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23510.Total Lipids in Small VLDL,29566,0.0156344110191167,0.00178535432542074,0.012135116541292,0.0191337054969413,2.10930639623075e-18
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23511.Phospholipids in Small VLDL,29566,0.00449190721768591,0.00175675483015615,0.00104866775057985,0.00793514668479197,0.0105648568518746
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23512.Cholesterol in Small VLDL,29566,0.00473988204129724,0.00175178988352767,0.001306373869583,0.00817339021301148,0.00681921658316888
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23513.Cholesteryl Esters in Small VLDL,29566,0.00927793074096469,0.00175885943780503,0.00583056624286684,0.0127252952390625,1.33711831236191e-07
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23514.Free Cholesterol in Small VLDL,29566,-0.00308208681216042,0.00174364927725231,-0.00649963939557495,0.000335465771254108,0.0771369308105576
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23515.Triglycerides in Small VLDL,29566,0.0283584362711903,0.00183572882351087,0.024760407777109,0.0319564647652715,1.26065452130598e-53
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23516.Concentration of Very Small VLDL Particles,29566,0.0192123314741755,0.00176427671806398,0.0157543491067701,0.0226703138415809,1.45715205594007e-27
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23517.Total Lipids in Very Small VLDL,29566,0.0200120661238362,0.00176995492251221,0.0165429544757123,0.0234811777719602,1.40102165682578e-29
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23518.Phospholipids in Very Small VLDL,29566,0.022246516514853,0.00176641783838986,0.0187843375516089,0.0257086954780972,2.81895699174164e-36
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23519.Cholesterol in Very Small VLDL,29566,0.00668502702460574,0.00179536116165776,0.00316611914775652,0.010203934901455,0.000196844759175747
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23520.Cholesteryl Esters in Very Small VLDL,29566,0.0027661555892329,0.00180937398733165,-0.000780217425937139,0.00631252860440294,0.12632684086444
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23521.Free Cholesterol in Very Small VLDL,29566,0.015151536966591,0.00177151141110993,0.0116793746008155,0.0186236993323665,1.25751759112237e-17
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23522.Triglycerides in Very Small VLDL,29566,0.0402426398805562,0.00179814499859398,0.036718275683312,0.0437670040778004,5.05949864770453e-110
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23523.Concentration of IDL Particles,29566,-0.00304800360744865,0.00176152436688664,-0.00650059136654647,0.000404584151649168,0.0835832775846466
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23524.Total Lipids in IDL,29566,-0.00603748375410135,0.00180593472544583,-0.00957711581597516,-0.00249785169222753,0.000829404059968853
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23525.Phospholipids in IDL,29566,-0.00584065217399034,0.00180814808959909,-0.00938462242960455,-0.00229668191837612,0.00123845546569842
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23526.Cholesterol in IDL,29566,-0.0119806090922928,0.00181206154589026,-0.0155322497222378,-0.00842896846234794,3.86685146723554e-11
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23527.Cholesteryl Esters in IDL,29566,-0.0117137751932052,0.00181132026363443,-0.0152639629099287,-0.00816358747648175,1.01539669253406e-10
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23528.Free Cholesterol in IDL,29566,-0.0124695195266671,0.00181141181048475,-0.0160198866752172,-0.00891915237811698,5.94119853171533e-12
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23529.Triglycerides in IDL,29566,0.0419308038797468,0.0017798458548642,0.038442306004213,0.0454193017552807,1.35422174652519e-121
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23530.Concentration of Large LDL Particles,29566,-0.0131311516581284,0.00174131870352195,-0.0165441363170314,-0.00971816699922538,4.80036526934149e-14
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23531.Total Lipids in Large LDL,29566,-0.011712656324505,0.00175533417050258,-0.0151531112986901,-0.00827220135031998,2.55733595836329e-11
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23532.Phospholipids in Large LDL,29566,-0.0125253768745157,0.00175296407256729,-0.0159611864567476,-0.00908956729228377,9.19074642161138e-13
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23533.Cholesterol in Large LDL,29566,-0.0157283704192049,0.00175839787369184,-0.0191748302516409,-0.0122819105867689,3.9414746219477e-19
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23534.Cholesteryl Esters in Large LDL,29566,-0.0141739706192618,0.00175284842901534,-0.0176095535401319,-0.0107383876983918,6.38627140055047e-16
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23535.Free Cholesterol in Large LDL,29566,-0.0197823888305746,0.00177723560339718,-0.0232657706132331,-0.0162990070479161,1.01114037402079e-28
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23536.Triglycerides in Large LDL,29566,0.0407784278255559,0.0017799493341926,0.0372897271305384,0.0442671285205734,3.73870312487118e-115
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23537.Concentration of Medium LDL Particles,29566,-0.00272543556994684,0.00174241351922379,-0.00614056606762546,0.000689694927731789,0.117787736109721
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23538.Total Lipids in Medium LDL,29566,-0.00609900927246668,0.00174015381780392,-0.00950971075536236,-0.002688307789571,0.000457510031243839
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23539.Phospholipids in Medium LDL,29566,-0.00880384872993184,0.00173771837814714,-0.0122097767511002,-0.00539792070876344,4.08005841204533e-07
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23540.Cholesterol in Medium LDL,29566,-0.00865847628435982,0.00173856494913564,-0.0120660635846657,-0.00525088898405397,6.38619570997529e-07
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23541.Cholesteryl Esters in Medium LDL,29566,-0.00428200491136764,0.00174421645137272,-0.00770066915605816,-0.000863340666677112,0.0140952233795336
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23542.Free Cholesterol in Medium LDL,29566,-0.0202748983296389,0.00173784340184877,-0.0236810713972625,-0.0168687252620153,2.20997151383644e-31
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23543.Triglycerides in Medium LDL,29566,0.0376054969508262,0.00179989834941986,0.0340776961859633,0.0411332977156891,3.07412809041573e-96
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23544.Concentration of Small LDL Particles,29566,-0.000971951205629915,0.00174132540776787,-0.00438494900485494,0.00244104659359511,0.576734257107634
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23545.Total Lipids in Small LDL,29566,-0.00823312025776576,0.0017380795065641,-0.0116397560906314,-0.00482648442490013,2.18012278752916e-06
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23546.Phospholipids in Small LDL,29566,-0.0130009652161725,0.00173546171401679,-0.0164024701756454,-0.00959946025669955,7.00686710228011e-14
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23547.Cholesterol in Small LDL,29566,-0.0108272489699715,0.00173657488027298,-0.0142309357353065,-0.00742356220463643,4.58380848933533e-10
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23548.Cholesteryl Esters in Small LDL,29566,-0.00483125865587685,0.00174145660151861,-0.00824451359485333,-0.00141800371690037,0.00553616455692815
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23549.Free Cholesterol in Small LDL,29566,-0.0254599014967089,0.00173569082373908,-0.0288618555112375,-0.0220579474821803,1.52134543819525e-48
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23550.Triglycerides in Small LDL,29566,0.0351005442290659,0.0018222659927439,0.0315289028832879,0.038672185574844,3.57363947506211e-82
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23551.Concentration of Very Large HDL Particles,29566,-0.0105048721629004,0.00204734658380863,-0.0145176714671653,-0.00649207285863552,2.90075512377906e-07
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23552.Total Lipids in Very Large HDL,29566,-0.0141250437326509,0.00205589202184221,-0.0181545920954616,-0.0100954953698401,6.52365766529499e-12
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23553.Phospholipids in Very Large HDL,29566,-0.0114024985428111,0.00205093342278794,-0.0154223280514755,-0.00738266903414672,2.72628779219626e-08
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23554.Cholesterol in Very Large HDL,29566,-0.0229255077351184,0.00205671548907916,-0.0269566700937135,-0.0188943453765232,8.48630640890804e-29
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23555.Cholesteryl Esters in Very Large HDL,29566,-0.0270601231136738,0.00207753854235538,-0.0311320986566904,-0.0229881475706573,1.12603720070179e-38
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23556.Free Cholesterol in Very Large HDL,29566,-0.00821471541850982,0.00195621000605725,-0.012048887030382,-0.00438054380663761,2.68523247209835e-05
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23557.Triglycerides in Very Large HDL,29566,0.0380441569216708,0.00175621600241456,0.0346019735569383,0.0414863402864033,2.94625225205443e-103
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23558.Concentration of Large HDL Particles,29566,-0.0215124247301064,0.00211422340872777,-0.0256563026112128,-0.0173685468489999,2.80891407366561e-24
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23559.Total Lipids in Large HDL,29566,-0.0179141421826288,0.00210036275749767,-0.0220308531873243,-0.0137974311779334,1.54459929513858e-17
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23560.Phospholipids in Large HDL,29566,-0.0121429169407403,0.00207769780076215,-0.0162152046302342,-0.00807062925124654,5.13699686885667e-09
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23561.Cholesterol in Large HDL,29566,-0.0293390854348825,0.002110230019345,-0.0334751362727987,-0.0252030345969663,8.31715821665499e-44
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23562.Cholesteryl Esters in Large HDL,29566,-0.0328728210566625,0.00210833919523976,-0.0370051658793325,-0.0287404762339926,1.36624593150422e-54
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23563.Free Cholesterol in Large HDL,29566,-0.016993804167935,0.00210277393357507,-0.0211152410777422,-0.0128723672581279,6.6333699920018e-16
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23564.Triglycerides in Large HDL,29566,0.0441786423860034,0.0017919336959408,0.0406664523419594,0.0476908324300474,7.32111835192758e-133
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23565.Concentration of Medium HDL Particles,29566,-0.00306017075696649,0.00191678804505286,-0.00681707532527009,0.00069673381133711,0.110385728404427
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23566.Total Lipids in Medium HDL,29566,0.00159142825119033,0.0018931133248282,-0.00211907386547293,0.0053019303678536,0.400556010416228
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23567.Phospholipids in Medium HDL,29566,0.00774000853987294,0.00187109912991709,0.00407265424523544,0.0114073628345104,3.53447567274685e-05
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23568.Cholesterol in Medium HDL,29566,-0.0133220629953484,0.00192901064974763,-0.0171029238688538,-0.00954120212184304,5.08006437157259e-12
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23569.Cholesteryl Esters in Medium HDL,29566,-0.0154587805296604,0.0019221064140877,-0.0192261091012723,-0.0116914519580485,9.11967760380953e-16
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23570.Free Cholesterol in Medium HDL,29566,-0.00410628157415936,0.00194702886213573,-0.00792245814394539,-0.000290105004373331,0.0349530734638112
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23571.Triglycerides in Medium HDL,29566,0.0482702813530011,0.00177189014559359,0.0447973766676377,0.0517431860383645,2.0325103436323e-161
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23572.Concentration of Small HDL Particles,29566,-0.00706150871808138,0.00174427908832156,-0.0104802957311916,-0.00364272170497112,5.17041650009253e-05
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23573.Total Lipids in Small HDL,29566,0.00809202422636091,0.00175629374340865,0.00464968848927996,0.0115343599634419,4.09350657501753e-06
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23574.Phospholipids in Small HDL,29566,0.0131969104969751,0.00176343739602454,0.00974057320076696,0.0166532477931832,7.43094091223086e-14
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23575.Cholesterol in Small HDL,29566,-0.0109701081158933,0.00174404934710501,-0.0143884448362192,-0.00755177139556752,3.21862253413977e-10
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23576.Cholesteryl Esters in Small HDL,29566,-0.0164150385790203,0.00173789503155154,-0.0198213128408613,-0.0130087643171792,3.79383082441642e-21
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23577.Free Cholesterol in Small HDL,29566,0.00751595426072257,0.00177340301869858,0.00404008434407336,0.0109918241773718,2.26048689060076e-05
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23578.Triglycerides in Small HDL,29566,0.0462212677470065,0.00186047255960052,0.0425747415301895,0.0498677939638236,7.31465462588545e-135
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,28307,0.00954175514033149,0.00179277597837111,0.00602791422272412,0.0130555960579389,1.03222822327034e-07
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,28307,-0.0157760363329145,0.00181552252742329,-0.0193344604866642,-0.0122176121791649,3.83221722175109e-18
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,28307,-0.0113514996345363,0.00179843934279409,-0.0148764407464127,-0.00782655852265991,2.79784180963255e-10
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,28307,-0.0188698600258741,0.00183359531210079,-0.0224637068375916,-0.0152760132141565,8.54073974547873e-25
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,28307,0.00901184877509906,0.00179108963225764,0.00550131309587408,0.012522384454324,4.89661540570326e-07
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,29256,0.00466412367530224,0.00174887084993525,0.00123633680942915,0.00809191054117532,0.00765887650646869
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,29256,-0.0330827000408033,0.00189619008985988,-0.0367992326169287,-0.029366167464678,8.01823267276504e-68
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23586.Cholesteryl Esters to Total Lipids in Very Large VLDL percentage,29256,-0.0347541407173472,0.00189237651203315,-0.0384631986809322,-0.0310450827537623,6.57121607047814e-75
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,29256,-0.0201982079247963,0.00184769289694999,-0.0238196860028183,-0.0165767298467743,9.21441415239292e-28
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,29256,0.0258684293710152,0.00185313786552513,0.0222362791545859,0.0295005795874444,3.82976940640063e-44
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,29561,0.0403375963719105,0.00183623471195301,0.0367385763364826,0.0439366164073384,4.16637698572107e-106
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,29561,-0.0150790565624125,0.00179377424409387,-0.0185948540808365,-0.0115632590439886,4.41795104126027e-17
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23591.Cholesteryl Esters to Total Lipids in Large VLDL percentage,29561,-0.023168447937326,0.00185659193330113,-0.0268073681265962,-0.0195295277480558,1.19534455713182e-35
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,29561,0.00819932041039496,0.00175938300515344,0.00475092972029422,0.0116477111004957,3.17066107116201e-06
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,29561,-0.00214245508125487,0.00174148787949802,-0.00555577132507099,0.00127086116256126,0.218615527858498
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,29566,-0.0168805553806314,0.00183235952268483,-0.0204719800450936,-0.0132891307161691,3.39175921182707e-20
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,29566,-0.0333768156105048,0.00190431080852061,-0.0371092647952052,-0.0296443664258044,1.98085447153857e-68
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,29566,-0.0352806656236928,0.00191685102489497,-0.0390376936324869,-0.0315236376148986,3.12630256859487e-75
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,29566,-0.0265594505198433,0.00186410812922556,-0.0302131024531254,-0.0229057985865612,6.56734381948869e-46
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,29566,0.0301286716519084,0.0018908315318099,0.026422641849561,0.0338347014542558,6.34808407750471e-57
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,29566,-0.0425552384598687,0.00184599425707401,-0.0461733872037338,-0.0389370897160036,1.47645625225573e-116
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,29566,-0.0260423504672131,0.00180316524159397,-0.0295765543407373,-0.0225081465936889,4.04163883183415e-47
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23601.Cholesteryl Esters to Total Lipids in Small VLDL percentage,29566,-0.0133911693311463,0.00176591840434789,-0.0168523694036681,-0.00992996925862438,3.47237378835491e-14
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,29566,-0.0400781459069351,0.00185922346685512,-0.0437222239019712,-0.0364340679118991,2.83382789381803e-102
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,29566,0.0314179567502514,0.00181740827020815,0.0278558365406434,0.0349800769598594,1.24964751197182e-66
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23604.Phospholipids to Total Lipids in Very Small VLDL percentage,29566,0.0229429437954012,0.00181857409878917,0.0193785385617744,0.0265073490290279,2.14236339142246e-36
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23605.Cholesterol to Total Lipids in Very Small VLDL percentage,29566,-0.0371985263433191,0.00189107808695355,-0.0409050393937481,-0.0334920132928902,1.36243549611418e-85
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23606.Cholesteryl Esters to Total Lipids in Very Small VLDL percentage,29566,-0.0374130525631796,0.00190980240725652,-0.0411562652814024,-0.0336698398449568,6.51253150791726e-85
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23607.Free Cholesterol to Total Lipids in Very Small VLDL percentage,29566,-0.0264722567287084,0.00176008016013223,-0.0299220138425675,-0.0230224996148492,6.1661918177121e-51
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23608.Triglycerides to Total Lipids in Very Small VLDL percentage,29566,0.0364991508495759,0.00187869397863681,0.0328169106514477,0.040181391047704,1.489450665034e-83
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23609.Phospholipids to Total Lipids in IDL percentage,29566,0.00496288158139957,0.00173844805655978,0.00155552339054241,0.00837023977225674,0.00430970204984222
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,29566,-0.0372175966174249,0.0018145490818049,-0.0407741128177625,-0.0336610804170872,7.67470440694791e-93
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23611.Cholesteryl Esters to Total Lipids in IDL percentage,29566,-0.0319482980101452,0.00180369369137153,-0.0354835376452334,-0.028413058375057,7.68951531280617e-70
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,29566,-0.0282639511233643,0.00177345252107464,-0.0317399180646706,-0.024787984182058,6.03760407485173e-57
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,29566,0.0483526283150201,0.00184427974773785,0.0447378400094539,0.0519674166205863,8.66899693910506e-150
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23614.Phospholipids to Total Lipids in Large LDL percentage,29566,-0.00356684638780838,0.00174970655966678,-0.00699627124475526,-0.000137421530861493,0.0415048649459275
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23615.Cholesterol to Total Lipids in Large LDL percentage,29566,-0.058142609398979,0.00182622579437005,-0.0617220119559443,-0.0545632068420137,9.75635164553161e-219
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23616.Cholesteryl Esters to Total Lipids in Large LDL percentage,29566,-0.034790092252793,0.00172739849978838,-0.0381757933123782,-0.0314043911932078,1.3126760032143e-89
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23617.Free Cholesterol to Total Lipids in Large LDL percentage,29566,-0.0371595625329653,0.00190674083767469,-0.0408967745748077,-0.0334223504911229,4.63658965748399e-84
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23618.Triglycerides to Total Lipids in Large LDL percentage,29566,0.0567435320722592,0.00180690871819239,0.0532019909846022,0.0602850731599163,5.74115871383394e-213
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23619.Phospholipids to Total Lipids in Medium LDL percentage,29566,-0.0206757436486593,0.00175010869259354,-0.0241059566861426,-0.0172455306111759,3.90479738308285e-32
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23620.Cholesterol to Total Lipids in Medium LDL percentage,29566,-0.0351405214574621,0.00176004538591292,-0.0385902104138514,-0.0316908325010727,4.17784417960854e-88
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23621.Cholesteryl Esters to Total Lipids in Medium LDL percentage,29566,0.0102664650946524,0.00178809656785316,0.00676179582166023,0.0137711343676446,9.47257688168704e-09
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23622.Free Cholesterol to Total Lipids in Medium LDL percentage,29566,-0.0456322233672865,0.00188543135367022,-0.0493276688204802,-0.0419367779140929,3.70692318450375e-128
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23623.Triglycerides to Total Lipids in Medium LDL percentage,29566,0.0521098640732927,0.00177428430979103,0.0486322668261023,0.0555874613204831,6.56076346657447e-187
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23624.Phospholipids to Total Lipids in Small LDL percentage,29566,-0.0173498365817119,0.00175961060758933,-0.020798673372587,-0.0139009997908368,6.72837828621883e-23
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23625.Cholesterol to Total Lipids in Small LDL percentage,29566,-0.0241766770404691,0.00175113929038046,-0.0276089100496149,-0.0207444440313234,3.18347878478922e-43
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23626.Cholesteryl Esters to Total Lipids in Small LDL percentage,29566,0.0155395992566345,0.00175875611857223,0.0120924372642329,0.0189867612490361,1.04993683250792e-18
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23627.Free Cholesterol to Total Lipids in Small LDL percentage,29566,-0.0469087505472285,0.00181817822020792,-0.050472379858836,-0.043345121235621,3.61348759303894e-145
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23628.Triglycerides to Total Lipids in Small LDL percentage,29566,0.050339968210532,0.00182073209880042,0.0467713332968832,0.0539086031241808,3.83212393440389e-166
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23629.Phospholipids to Total Lipids in Very Large HDL percentage,29553,0.00116170613359055,0.001970651324585,-0.00270077046259604,0.00502418272977714,0.555527978096102
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23630.Cholesterol to Total Lipids in Very Large HDL percentage,29553,-0.0289727591190458,0.00182900707806063,-0.0325576129920446,-0.025387905246047,2.78046046729117e-56
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23631.Cholesteryl Esters to Total Lipids in Very Large HDL percentage,29553,-0.0477202519228979,0.001742801102341,-0.0511361420834862,-0.0443043617623095,4.98288430040073e-163
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23632.Free Cholesterol to Total Lipids in Very Large HDL percentage,29553,0.0192712247748885,0.00207195916862102,0.0152101848043913,0.0233322647453857,1.48470946483807e-20
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23633.Triglycerides to Total Lipids in Very Large HDL percentage,29553,0.0424517519573521,0.00192625396899176,0.0386762941781282,0.0462272097365759,8.94621769814329e-107
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23634.Phospholipids to Total Lipids in Large HDL percentage,29566,0.0455080243510427,0.00191595024212841,0.041752761876471,0.0492632868256144,1.50318043447726e-123
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23635.Cholesterol to Total Lipids in Large HDL percentage,29566,-0.0582426113961961,0.00195219723776672,-0.0620689179822189,-0.0544163048101734,1.013968971919e-192
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23636.Cholesteryl Esters to Total Lipids in Large HDL percentage,29566,-0.0623858370983419,0.0019162709489601,-0.0661417281583037,-0.0586299460383801,1.89159599316556e-228
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23637.Free Cholesterol to Total Lipids in Large HDL percentage,29566,-0.00661363814693605,0.00191393987827511,-0.0103649603083553,-0.00286231598551684,0.000550024141794129
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23638.Triglycerides to Total Lipids in Large HDL percentage,29566,0.0537037919505843,0.00188246795826731,0.0500141547523804,0.0573934291487882,1.29521434512758e-176
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23639.Phospholipids to Total Lipids in Medium HDL percentage,29566,0.048515216282679,0.00193365408592033,0.0447252542742752,0.0523051782910829,1.76549505774796e-137
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23640.Cholesterol to Total Lipids in Medium HDL percentage,29566,-0.0544522769070894,0.00189562739143846,-0.0581677065943088,-0.0507368472198701,5.35430747099599e-179
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23641.Cholesteryl Esters to Total Lipids in Medium HDL percentage,29566,-0.054466035316253,0.00184251630938276,-0.0580773672826432,-0.0508547033498628,2.74000054725567e-189
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23642.Free Cholesterol to Total Lipids in Medium HDL percentage,29566,-0.0209202377384255,0.00203687531292357,-0.0249125133517557,-0.0169279621250953,1.05044894086972e-24
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23643.Triglycerides to Total Lipids in Medium HDL percentage,29566,0.0535998534875218,0.00185227096910119,0.0499694023880835,0.0572303045869602,1.38558561034295e-181
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23644.Phospholipids to Total Lipids in Small HDL percentage,29566,0.0359992069541429,0.00178540191403595,0.0324998192026324,0.0394985947056533,8.31431637172026e-90
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23645.Cholesterol to Total Lipids in Small HDL percentage,29566,-0.0555254652937091,0.0017646429853045,-0.0589841655449059,-0.0520667650425122,8.71893214356966e-214
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23646.Cholesteryl Esters to Total Lipids in Small HDL percentage,29566,-0.0540704864176761,0.00175510942588784,-0.0575105008924163,-0.050630471942936,3.67667710866834e-205
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23647.Free Cholesterol to Total Lipids in Small HDL percentage,29566,-0.00327592269774105,0.00187014059539905,-0.00694139826472319,0.000389552869241082,0.0798360168795674
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23648.Triglycerides to Total Lipids in Small HDL percentage,29566,0.0507763184382519,0.0018875543129946,0.0470767119847825,0.0544759248917214,1.71051856747546e-157
PLA2G15,Phospholipase A2 group XV,Working and living environment,X24003.Nitrogen dioxide air pollution; 2010,50910,-0.00169956485305204,0.00151403458986498,-0.00466707264918739,0.00126794294308332,0.26163807511071
PLA2G15,Phospholipase A2 group XV,Working and living environment,X24004.Nitrogen oxides air pollution; 2010,50910,-0.000367805027704465,0.00147773299359177,-0.00326416169514433,0.0025285516397354,0.803440560516594
PLA2G15,Phospholipase A2 group XV,Working and living environment,X24005.Particulate matter air pollution (pm10); 2010,47470,0.000656488460446583,0.00141540511878433,-0.0021177055723707,0.00343068249326387,0.642781240738962
PLA2G15,Phospholipase A2 group XV,Working and living environment,X24006.Particulate matter air pollution (pm2.5); 2010,47470,0.0011358225871831,0.00154105337434824,-0.00188464202653945,0.00415628720090566,0.461099850114523
PLA2G15,Phospholipase A2 group XV,Working and living environment,X24007.Particulate matter air pollution (pm2.5) absorbance; 2010,47470,-0.000645369170998083,0.00152005960413123,-0.00362468599509529,0.00233394765309912,0.671153307120824
PLA2G15,Phospholipase A2 group XV,Working and living environment,X24008.Particulate matter air pollution 2.5-10um; 2010,47470,-0.00151646249656135,0.00139426354516938,-0.00424921904509334,0.00121629405197064,0.276757785161586
PLA2G15,Phospholipase A2 group XV,Working and living environment,X24009.Traffic intensity on the nearest road,50910,-0.0540119339914469,0.0612771402585726,-0.174115128898249,0.0660912609153554,0.378085542666387
PLA2G15,Phospholipase A2 group XV,Working and living environment,X24010.Inverse distance to the nearest road,50910,0.0032811388411146,0.00132173852904944,0.000690531324177687,0.00587174635805151,0.0130517406146539
PLA2G15,Phospholipase A2 group XV,Working and living environment,X24011.Traffic intensity on the nearest major road,50910,0.000747626682872574,0.00132190977407203,-0.00184331647430861,0.00333856984005376,0.571691617327585
PLA2G15,Phospholipase A2 group XV,Working and living environment,X24012.Inverse distance to the nearest major road,50910,-0.000696202320308158,0.00134414630081266,-0.00333072906990097,0.00193832442928465,0.604494501388896
PLA2G15,Phospholipase A2 group XV,Working and living environment,X24013.Total traffic load on major roads,50910,-0.0482572948523631,0.0426430542736322,-0.131837681228682,0.0353230915239559,0.257784156078202
PLA2G15,Phospholipase A2 group XV,Working and living environment,X24015.Sum of road length of major roads within 100m,50910,-0.0412159256972031,0.041320207011617,-0.122203531439972,0.0397716800455662,0.318538132004
PLA2G15,Phospholipase A2 group XV,Working and living environment,X24016.Nitrogen dioxide air pollution; 2005,50910,-0.00351402684443343,0.00151091712193978,-0.00647542440343539,-0.00055262928543146,0.0200353988567637
PLA2G15,Phospholipase A2 group XV,Working and living environment,X24017.Nitrogen dioxide air pollution; 2006,50910,-0.00368763333754764,0.00150914990043821,-0.00664556714240654,-0.000729699532688751,0.0145482596617525
PLA2G15,Phospholipase A2 group XV,Working and living environment,X24018.Nitrogen dioxide air pollution; 2007,50910,-0.00354760096822818,0.00149295624444547,-0.0064737952073413,-0.00062140672911506,0.01749443913715
PLA2G15,Phospholipase A2 group XV,Working and living environment,X24019.Particulate matter air pollution (pm10); 2007,50807,-0.00142562875656878,0.00146585734258084,-0.00429870914802722,0.00144745163488966,0.330778514546875
PLA2G15,Phospholipase A2 group XV,Working and living environment,X24020.Average daytime sound level of noise pollution,50910,4.50115961002719e-05,0.00132788312926514,-0.0025576393372594,0.00264766252945994,0.972959213214238
PLA2G15,Phospholipase A2 group XV,Working and living environment,X24021.Average evening sound level of noise pollution,50910,8.27871833917967e-05,0.00132783544085714,-0.00251977028068819,0.00268534464747179,0.950286369364742
PLA2G15,Phospholipase A2 group XV,Working and living environment,X24022.Average night-time sound level of noise pollution,50910,4.61829055846758e-05,0.00132789087161346,-0.0025564832027777,0.00264884901394705,0.972255988988579
PLA2G15,Phospholipase A2 group XV,Working and living environment,X24023.Average 16-hour sound level of noise pollution,50910,7.06129333503061e-05,0.00132784677873589,-0.00253196675297203,0.00267319261967264,0.957589874539048
PLA2G15,Phospholipase A2 group XV,Working and living environment,X24024.Average 24-hour sound level of noise pollution,50910,7.47501278228487e-05,0.00132785878957499,-0.00252785309974414,0.00267735335538983,0.955108032438962
PLA2G15,Phospholipase A2 group XV,Health and medical history,X2405.Number of children fathered,23426,-0.101317357878025,0.0452197304525384,-0.189948029565001,-0.0126866861910499,0.0250641610768811
PLA2G15,Phospholipase A2 group XV,Working and living environment,"X24500.Greenspace percentage, buffer 1000m",45408,0.00210900960470246,0.00155758955389069,-0.000943865920923296,0.00516188513032821,0.175736287657572
PLA2G15,Phospholipase A2 group XV,Working and living environment,"X24501.Domestic garden percentage, buffer 1000m",45408,-0.000321057012027858,0.00141154183668738,-0.00308767901193513,0.00244556498787941,0.820073865672014
PLA2G15,Phospholipase A2 group XV,Working and living environment,"X24502.Water percentage, buffer 1000m",45408,0.00116978612284589,0.00140312596840967,-0.00158034077523707,0.00391991302092885,0.404454443699864
PLA2G15,Phospholipase A2 group XV,Working and living environment,"X24503.Greenspace percentage, buffer 300m",45408,0.00172167565160706,0.00146550056414199,-0.00115070545411124,0.00459405675732536,0.240079376502698
PLA2G15,Phospholipase A2 group XV,Working and living environment,"X24504.Domestic garden percentage, buffer 300m",45408,-0.000701637201441104,0.00142344971387378,-0.00349159864063372,0.00208832423775151,0.622076280425706
PLA2G15,Phospholipase A2 group XV,Working and living environment,"X24505.Water percentage, buffer 300m",45408,-0.000359897268396764,0.00141065964606034,-0.00312479017467503,0.00240499563788151,0.798626218931158
PLA2G15,Phospholipase A2 group XV,Working and living environment,"X24506.Natural environment percentage, buffer 1000m",51146,0.00184266234787824,0.00148727252043226,-0.001072391792169,0.00475771648792547,0.215368193770405
PLA2G15,Phospholipase A2 group XV,Working and living environment,"X24507.Natural environment percentage, buffer 300m",51146,0.000851716273895419,0.00139852175831816,-0.00188938637240818,0.00359281892019901,0.542519313450338
PLA2G15,Phospholipase A2 group XV,Working and living environment,X24508.Distance (Euclidean) to coast,51146,-0.00212030667907148,0.0013292883474738,-0.00472571184012013,0.000485098481977166,0.110702979767285
PLA2G15,Phospholipase A2 group XV,Health and medical history,X2684.Years since last breast cancer screening  or  mammogram,11245,0.105873721463013,0.0638233834211715,-0.0192201100424835,0.230967552968509,0.097172991685974
PLA2G15,Phospholipase A2 group XV,Health and medical history,X2704.Years since last cervical smear test,21142,0.0596584115964223,0.0470171985482137,-0.0324952975580765,0.151812120750921,0.204503696953208
PLA2G15,Phospholipase A2 group XV,Health and medical history,X2714.Age when periods started (menarche),26974,0.0736162946480407,0.0395999414530418,-0.00399959059992121,0.151232179896003,0.0630380137273764
PLA2G15,Phospholipase A2 group XV,Health and medical history,X2734.Number of live births,27812,0.0908040490305315,0.0379464914874382,0.0164289257151526,0.16517917234591,0.0167201238636756
PLA2G15,Phospholipase A2 group XV,Health and medical history,X2744.Birth weight of first child,22054,-0.180822300963151,0.0424154782822721,-0.263956638396404,-0.0976879635298975,2.02430029416702e-05
PLA2G15,Phospholipase A2 group XV,Health and medical history,X2754.Age at first live birth,18777,-0.0112834287233074,0.00222243951402377,-0.015639410170794,-0.00692744727582078,3.87014201766002e-07
PLA2G15,Phospholipase A2 group XV,Health and medical history,X2764.Age at last live birth,18726,-0.00533574959435582,0.00214774519497985,-0.00954533017651633,-0.00112616901219532,0.0129875153348473
PLA2G15,Phospholipase A2 group XV,Health and medical history,X2794.Age started oral contraceptive pill,21337,0.00232435684403081,0.00241234245629183,-0.00240383437030118,0.00705254805836279,0.335294098489747
PLA2G15,Phospholipase A2 group XV,Health and medical history,X2804.Age when last used oral contraceptive pill,19351,-0.0081246079324728,0.00208891473816432,-0.0122188808192749,-0.00403033504567073,0.00010083191088158
PLA2G15,Phospholipase A2 group XV,Lifestyle factors,X2867.Age started smoking in former smokers,12615,-0.00497515201349825,0.00274360210625448,-0.010352612141757,0.000402308114760543,0.0697993247934101
PLA2G15,Phospholipase A2 group XV,Mental health,"X28735.Feeling anxious, nervous or on edge over the last 2 weeks",19637,0.219503718349564,0.0572398732340943,0.107313566810739,0.331693869888389,0.000126057004592445
PLA2G15,Phospholipase A2 group XV,Mental health,X28736.Not being able to stop or control worrying over the last 2 weeks,19629,0.27261977407764,0.0632260366835561,0.14869674217787,0.39654280597741,1.6270072952829e-05
PLA2G15,Phospholipase A2 group XV,Mental health,X28737.Little interest or pleasure in doing things over the last 2 weeks,19668,0.351942815756441,0.0648974513157807,0.224743811177511,0.479141820335372,5.92783553011141e-08
PLA2G15,Phospholipase A2 group XV,Mental health,"X28738.Feeling down, depressed or hopeless over the last 2 weeks",19610,0.287146583060461,0.063378388810398,0.162924940992081,0.411368225128841,5.91439831361411e-06
PLA2G15,Phospholipase A2 group XV,Mental health,X28739.Difficulty with standing for long periods,19687,0.430354992538987,0.0555700762413171,0.321437643106006,0.539272341971969,1.00696409646765e-14
PLA2G15,Phospholipase A2 group XV,Mental health,X28740.Difficulty with taking care of household responsibilities,19734,0.440483289428297,0.0617591232896875,0.319435407780509,0.561531171076085,1.0213804154692e-12
PLA2G15,Phospholipase A2 group XV,Mental health,X28741.Difficulty learning a new task,19575,0.396288343315882,0.0701259081267342,0.258841563387483,0.533735123244281,1.61646410685017e-08
PLA2G15,Phospholipase A2 group XV,Mental health,X28742.Difficulty with joining in community activities,18868,0.45841942064904,0.0700892422754873,0.321044505789085,0.595794335508995,6.28835603537265e-11
PLA2G15,Phospholipase A2 group XV,Mental health,X28743.Difficulty with being emotionally affected by health problems,19603,0.380608348455252,0.059677268707246,0.26364090178905,0.497575795121454,1.83694214965528e-10
PLA2G15,Phospholipase A2 group XV,Mental health,X28744.Difficulty with concentrating on doing something for ten minutes,19733,0.484438332585701,0.0836639704039625,0.320456950593935,0.648419714577468,7.13340054336189e-09
PLA2G15,Phospholipase A2 group XV,Lifestyle factors,X2887.Number of cigarettes previously smoked daily,11978,0.292566954553187,0.0611342846363683,0.172743756665905,0.412390152440469,1.72477800052617e-06
PLA2G15,Phospholipase A2 group XV,Lifestyle factors,X2897.Age stopped smoking,12615,0.025570313380822,0.00285479278518816,0.0199749195218532,0.0311657072397908,3.80147319066557e-19
PLA2G15,Phospholipase A2 group XV,Mental health,X29001#0.Mental health conditions experienced by first degree blood relatives_None of the above,17620,-0.00442332006362648,0.00450592393992492,-0.0132549309858793,0.00440829085862635,0.326277064255854
PLA2G15,Phospholipase A2 group XV,Mental health,X29001#1.Mental health conditions experienced by first degree blood relatives_Depression,17620,0.00568460369944869,0.00490899706537398,-0.00393703054868432,0.0153062379475817,0.246880983524365
PLA2G15,Phospholipase A2 group XV,Mental health,X29001#3.Mental health conditions experienced by first degree blood relatives_Schizophrenia,17620,0.0126172952664703,0.0164020125441264,-0.0195306493200175,0.0447652398529581,0.441753527834227
PLA2G15,Phospholipase A2 group XV,Mental health,X29001#4.Mental health conditions experienced by first degree blood relatives_Any other type of psychosis or psychotic illness,17620,-0.0209992158916733,0.0168509161815903,-0.0540270116075902,0.0120285798242436,0.212716182592603
PLA2G15,Phospholipase A2 group XV,Mental health,X29001#5.Mental health conditions experienced by first degree blood relatives_A personality disorder,17620,0.0123321444445516,0.0187425715564748,-0.024403295806139,0.0490675846952421,0.510562766733714
PLA2G15,Phospholipase A2 group XV,Mental health,X29001#7.Mental health conditions experienced by first degree blood relatives_Attention deficit or attention deficit and hyperactivity disorder,17620,-0.00563412797191803,0.0158004976842608,-0.0366031034330691,0.0253348474892331,0.72141116464972
PLA2G15,Phospholipase A2 group XV,Mental health,X29001#8.Mental health conditions experienced by first degree blood relatives_An anxiety disorder,17620,0.00563588786481427,0.00708505234647984,-0.00825081473428621,0.0195225904639148,0.426355698775375
PLA2G15,Phospholipase A2 group XV,Mental health,X29001#9.Mental health conditions experienced by first degree blood relatives_An eating disorder,17620,0.00805835072474055,0.0127511308112569,-0.0169338656653229,0.033050567114804,0.527413734035275
PLA2G15,Phospholipase A2 group XV,Mental health,X29002.Recent lack of interest or pleasure in doing things,17501,0.249524320207096,0.0665825472984826,0.11902252750207,0.380026112912122,0.000179113554311229
PLA2G15,Phospholipase A2 group XV,Mental health,X29003.Recent feelings of depression,17485,0.251661988486382,0.0645253393699824,0.125192323321217,0.378131653651548,9.64713541991732e-05
PLA2G15,Phospholipase A2 group XV,Mental health,"X29004.Trouble falling or staying asleep, or sleeping too much",17507,0.116095935366235,0.0522087491853113,0.0137667869630248,0.218425083769445,0.0261822086646097
PLA2G15,Phospholipase A2 group XV,Mental health,X29005.Recent feelings of tiredness or low energy,17518,0.287060466727181,0.05277566710762,0.183620159196246,0.390500774258117,5.42204858808837e-08
PLA2G15,Phospholipase A2 group XV,Mental health,X29006.Recent poor appetite or overeating,17530,0.320765926214223,0.0726387224083117,0.178394030293932,0.463137822134514,1.01189117536593e-05
PLA2G15,Phospholipase A2 group XV,Mental health,X29007.Recent feelings of inadequacy,17458,0.111129251299216,0.0700329000065365,-0.0261352327135952,0.248393735312028,0.112572693519117
PLA2G15,Phospholipase A2 group XV,Mental health,X29008.Recent trouble concentrating on things,17526,0.177808066361383,0.0688432366026141,0.0428753226202593,0.312740810102506,0.00980834892068689
PLA2G15,Phospholipase A2 group XV,Mental health,X29009.Recent changes in speed or amount of moving or speaking,17511,0.242281236924022,0.120098928514251,0.00688733703609046,0.477675136811953,0.0436745345896756
PLA2G15,Phospholipase A2 group XV,Mental health,X29010.Recent thoughts of suicide or self-harm,17424,0.433952249427,0.132777532334288,0.173708286051797,0.694196212802204,0.00108418506621307
PLA2G15,Phospholipase A2 group XV,Mental health,X29038#0.Substances taken for depression_None of options listed,16091,-0.0282003609241127,0.00914959203726308,-0.0461335613171483,-0.010267160531077,0.0020586294502153
PLA2G15,Phospholipase A2 group XV,Mental health,X29038#1.Substances taken for depression_Drugs or alcohol (more than once),16091,-0.00914212257647122,0.0178552493793427,-0.0441384113599829,0.0258541662070405,0.608648835470841
PLA2G15,Phospholipase A2 group XV,Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),16091,-0.0109609795587437,0.00909440831190332,-0.0287860198500742,0.00686406073258682,0.228126923824118
PLA2G15,Phospholipase A2 group XV,Mental health,X29038#3.Substances taken for depression_Unprescribed medication (more than once),16091,0.00696889478770771,0.0266699834649557,-0.0453042728036055,0.0592420623790209,0.793863700992439
PLA2G15,Phospholipase A2 group XV,Mental health,X29039#1.Use of specific medications_Citalopram (sometimes called Cipramil),16091,-0.017750409853116,0.0169205986310498,-0.0509147831699737,0.0154139634637416,0.294174796489345
PLA2G15,Phospholipase A2 group XV,Mental health,X29039#2.Use of specific medications_Fluoxetine (Prozac or Oxactin),16091,0.0150128659016097,0.0182802064882394,-0.0208163388153395,0.050842070618559,0.411508385641767
PLA2G15,Phospholipase A2 group XV,Mental health,X29039#3.Use of specific medications_Sertraline (Lustral),16091,0.00622465088658223,0.020503108735179,-0.0339614422343685,0.046410744007533,0.761440033567961
PLA2G15,Phospholipase A2 group XV,Mental health,X29039#5.Use of specific medications_Amitriptyline (Elavil),16091,0.0167681751491679,0.0238171791399962,-0.0299134959652247,0.0634498462635605,0.481419934055074
PLA2G15,Phospholipase A2 group XV,Mental health,X29039#7.Use of specific medications_Other antidepressant(s),16091,0.0170318159786138,0.0178183822083677,-0.0178922131497869,0.0519558451070145,0.3391591244669
PLA2G15,Phospholipase A2 group XV,Mental health,X29047#0.Activities undertaken to treat depression_None of options listed,16091,-0.018776197039128,0.00898907850801419,-0.0363947909148358,-0.00115760316342022,0.0367433239204293
PLA2G15,Phospholipase A2 group XV,Mental health,X29051#0.Manifestations of mania or irritability_None of options listed,16091,-0.0135061754620858,0.013953670105715,-0.0408553688692871,0.0138430179451156,0.333093906742916
PLA2G15,Phospholipase A2 group XV,Mental health,X29051#1.Manifestations of mania or irritability_More active than usual,16091,-0.0304018574620617,0.0219693680380761,-0.073461818816691,0.0126581038925675,0.166429908658802
PLA2G15,Phospholipase A2 group XV,Mental health,X29051#2.Manifestations of mania or irritability_More confident than usual,16091,-0.0209956300700454,0.0281602089377674,-0.0761896395880694,0.0341983794479786,0.455933323842053
PLA2G15,Phospholipase A2 group XV,Mental health,X29051#3.Manifestations of mania or irritability_Easily distracted,16091,-0.00374113843745063,0.0175691705436822,-0.0381767127030678,0.0306944358281665,0.831378270739804
PLA2G15,Phospholipase A2 group XV,Mental health,X29051#4.Manifestations of mania or irritability_More creative or had more ideas than usual,16091,-0.0292995220238264,0.0285378653782142,-0.0852337381651262,0.0266346941174734,0.304582219487713
PLA2G15,Phospholipase A2 group XV,Mental health,X29051#5.Manifestations of mania or irritability_Neded less sleep than usual,16091,-0.0375285837586644,0.0277967707963106,-0.0920102545194332,0.0169530870021043,0.177001028269815
PLA2G15,Phospholipase A2 group XV,Mental health,X29051#6.Manifestations of mania or irritability_Thoughts were racing,16091,-0.0180031322642633,0.0151039806270323,-0.0476069342932467,0.01160066976472,0.233299936450029
PLA2G15,Phospholipase A2 group XV,Mental health,X29051#7.Manifestations of mania or irritability_More restless than usual,16091,-0.00217892159402577,0.0147026945864746,-0.0309962029835159,0.0266383597954644,0.88218774279878
PLA2G15,Phospholipase A2 group XV,Mental health,X29051#8.Manifestations of mania or irritability_More talkative than usual,16091,-0.0333134533106991,0.0209364417390271,-0.0743488791191923,0.00772197249779401,0.111590819027944
PLA2G15,Phospholipase A2 group XV,Mental health,X29058.Recent feelings or nervousness or anxiety,17243,0.156386389279128,0.0610329401870971,0.0367618265124174,0.276010952045838,0.0104057424959033
PLA2G15,Phospholipase A2 group XV,Mental health,X29059.Recent inability to stop or control worrying,17263,0.193398716364308,0.0634744799130086,0.0689887357348115,0.317808696993805,0.00231584447213869
PLA2G15,Phospholipase A2 group XV,Mental health,X29060.Recent worrying too much about different things,17251,0.184849559301464,0.0584956110622909,0.0701981616193743,0.299500956983555,0.00158010171475019
PLA2G15,Phospholipase A2 group XV,Mental health,X29061.Recent trouble relaxing,17254,0.228826613116301,0.0619312324214608,0.107441397570238,0.350211828662364,0.000220697193866018
PLA2G15,Phospholipase A2 group XV,Mental health,X29062.Recent restlessness,17274,0.275401433632974,0.0875643551070648,0.103775297623127,0.447027569642821,0.00166293788412384
PLA2G15,Phospholipase A2 group XV,Mental health,X29063.Recent easy annoyance or irritability,17229,0.160725214841937,0.0626665940160173,0.0378986905705427,0.283551739113331,0.0103329101858889
PLA2G15,Phospholipase A2 group XV,Mental health,X29064.Recent feelings of foreboding,17217,0.281637552467531,0.0715547586256213,0.141390225561313,0.421884879373748,8.31865171755226e-05
PLA2G15,Phospholipase A2 group XV,Mental health,X29065#1.Symptoms of panic attack_Heart was pounding or racing,16091,-0.00365097197568596,0.00963543890528096,-0.0225364322300366,0.0152344882786647,0.704759099087623
PLA2G15,Phospholipase A2 group XV,Mental health,X29065#11.Symptoms of panic attack_Felt like things weren't real or detached from self,16091,-0.0258834320602722,0.0161579046154292,-0.0575529251065135,0.00578606098596912,0.109196212018337
PLA2G15,Phospholipase A2 group XV,Mental health,X29065#12.Symptoms of panic attack_Afraid of losing control or 'going crazy',16091,0.0183660100199637,0.02080667883344,-0.0224150804935787,0.0591471005335061,0.377412758889194
PLA2G15,Phospholipase A2 group XV,Mental health,X29065#13.Symptoms of panic attack_Afraid I was going to die,16091,-0.0120578456896745,0.0219629129309527,-0.0551051550343417,0.0309894636549928,0.58300662228294
PLA2G15,Phospholipase A2 group XV,Mental health,X29065#2.Symptoms of panic attack_Sweating,16091,-0.00576452986139439,0.0145508465453776,-0.0342841890903344,0.0227551293675456,0.691988884296819
PLA2G15,Phospholipase A2 group XV,Mental health,X29065#3.Symptoms of panic attack_Trembling or shaking,16091,0.00942714815748988,0.0156556479297901,-0.0212579217848987,0.0401122180998784,0.547078545537036
PLA2G15,Phospholipase A2 group XV,Mental health,X29065#6.Symptoms of panic attack_Pain or discomfort in chest,16091,0.00579554625924124,0.0156733754074411,-0.0249242695393434,0.0365153620578258,0.711558634124799
PLA2G15,Phospholipase A2 group XV,Mental health,X29065#7.Symptoms of panic attack_Nauseous or felt sick in the stomach,16091,0.00257673109329001,0.0145208460152808,-0.0258841270966604,0.0310375892832405,0.859156794718272
PLA2G15,Phospholipase A2 group XV,Mental health,X29065#9.Symptoms of panic attack_Felt hot or cold,16091,0.00100193426803231,0.0190888884935903,-0.0364122871794046,0.0384161557154692,0.958140647100235
PLA2G15,Phospholipase A2 group XV,Mental health,X29076.Felt loved as a child,17192,-0.0623966342683099,0.0537292113510055,-0.167705888516281,0.0429126199796609,0.245529240923183
PLA2G15,Phospholipase A2 group XV,Mental health,X29077.Physically abused by family as a child,17218,0.0209611014097976,0.0726768473535145,-0.121485519403091,0.163407722222686,0.773032472897748
PLA2G15,Phospholipase A2 group XV,Mental health,X29078.Felt hated by family member as a child,17189,0.158573684672751,0.0737668573554591,0.0139906442560509,0.303156725089451,0.0315960208057495
PLA2G15,Phospholipase A2 group XV,Mental health,X29079.Sexually molested as a child,17063,0.0558863814474702,0.0988665454278599,-0.137892047591135,0.249664810486076,0.571896955850219
PLA2G15,Phospholipase A2 group XV,Mental health,X29080.Someone to take to doctor when needed as a child,17157,-0.156976153866375,0.0790349888531323,-0.311884732018514,-0.00206757571423527,0.047031433565481
PLA2G15,Phospholipase A2 group XV,Mental health,X29081.Stopped from seeing friends or family by partner or ex-partner as an adult,17195,0.0108747695855943,0.102228507144105,-0.189493104416851,0.21124264358804,0.915284423277545
PLA2G15,Phospholipase A2 group XV,Mental health,X29082.Belittlement by partner or ex-partner as an adult,17090,0.101210599815791,0.0800860045762075,-0.0557579691535757,0.258179168785158,0.206328455958971
PLA2G15,Phospholipase A2 group XV,Mental health,X29083.Physical violence by partner or ex-partner as an adult,17209,0.0458910200004403,0.0899121034205847,-0.130336702703906,0.222118742704786,0.609778725082623
PLA2G15,Phospholipase A2 group XV,Mental health,X29084.Sexual interference by partner or ex-partner without consent as an adult,17159,0.122770697385827,0.126858594146469,-0.125872147141252,0.371413541912907,0.333169925766714
PLA2G15,Phospholipase A2 group XV,Mental health,X29085.Sexual intercourse by partner or ex-partner without consent as an adult,17158,0.0566945023151868,0.121466122668659,-0.181379098115386,0.294768102745759,0.640683567222476
PLA2G15,Phospholipase A2 group XV,Mental health,X29086.Experienced a violent or sexual assault,17209,0.00633997682841664,0.101892311005386,-0.193368952742139,0.206048906398973,0.950386504755387
PLA2G15,Phospholipase A2 group XV,Mental health,X29087.Experienced a life-threatening injury or illness,17212,0.276613086195192,0.0638393898141343,0.151487882159489,0.401738290230895,1.47956883162617e-05
PLA2G15,Phospholipase A2 group XV,Mental health,X29088.Experienced a marital separation or divorce,17218,0.0587455479540107,0.059310562004646,-0.0575031535750954,0.174994249483117,0.321956600342948
PLA2G15,Phospholipase A2 group XV,Mental health,X29089.Experienced the death of a spouse or partner,17236,0.0888762197596987,0.0808893095244039,-0.0696668269081329,0.24741926642753,0.271897390938621
PLA2G15,Phospholipase A2 group XV,Mental health,X29090.Experienced the death of a close friend or family member due to suicide,17213,0.0951188838499751,0.0740592550572584,-0.0500372560622514,0.240275023762202,0.199032665921076
PLA2G15,Phospholipase A2 group XV,Lifestyle factors,X29091.Frequency of drinking alcohol,17223,-0.10714719881769,0.0491287582013283,-0.203439564892294,-0.010854832743087,0.0292008601452767
PLA2G15,Phospholipase A2 group XV,Lifestyle factors,X29092.Amount of alcohol drunk on a typical drinking day,15359,-0.012733450403151,0.0567374079791036,-0.123938770042194,0.098471869235892,0.822427446819266
PLA2G15,Phospholipase A2 group XV,Lifestyle factors,X29093.Frequency of consuming six or more units of alcohol,15395,-0.0505468178637872,0.0570374416819186,-0.162340203560348,0.0612465678327733,0.37552138236793
PLA2G15,Phospholipase A2 group XV,Mental health,X29104.Ever used cannabis,17210,-0.158418383579341,0.0705918622096701,-0.296778433510294,-0.0200583336483877,0.0248357353262743
PLA2G15,Phospholipase A2 group XV,Mental health,X29108.Ever thought that life not worth living,17128,0.0253332805255354,0.0620626250482313,-0.096309464568998,0.146976025620069,0.68314003416117
PLA2G15,Phospholipase A2 group XV,Mental health,X29109.Ever contemplated self-harm,17174,0.0172840042591681,0.084002658760892,-0.14736120691218,0.181929215430516,0.836984388725254
PLA2G15,Phospholipase A2 group XV,Mental health,X29111.Ever self-harmed,17200,0.161419858452104,0.135038848184816,-0.103256283990135,0.426096000894344,0.231963419700477
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X29132.Ever had recurrent episodes of excessive overeating or binge eating,17193,-0.171919987564922,0.088192949713948,-0.344778169004261,0.000938193874415572,0.0512684568609867
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X29136#1.Actions and feelings during periods of overeating or binge eating_Eaten much more rapidly than normal,17403,-0.0488188717012562,0.0204935473051751,-0.0889862244193994,-0.00865151898311291,0.0172221876434896
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X29136#2.Actions and feelings during periods of overeating or binge eating_Eaten until feeling uncomfortably full,17403,-0.0555900490411588,0.015738633501683,-0.0864377707044574,-0.0247423273778602,0.000413378748600326
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X29136#3.Actions and feelings during periods of overeating or binge eating_Eaten large amounts of food when not physically hungry,17403,-0.048457749659872,0.0168735417770727,-0.0815298915429345,-0.0153856077768095,0.00408610473254128
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X29136#4.Actions and feelings during periods of overeating or binge eating_Eaten alone because of feeling embarrassed by overeating,17403,-0.0433995531992156,0.0229332553559971,-0.0883487336969699,0.00154962729853871,0.0584504641915262
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X29149.Dependency of self-esteem on body shape or weight currently,17176,-0.100168095652792,0.0556679280045695,-0.209277234541748,0.00894104323616458,0.0719751874854796
PLA2G15,Phospholipase A2 group XV,Health and medical history,X29153.Pain or discomfort today,17203,0.250048064984294,0.0527603896036403,0.146637701361159,0.353458428607429,2.16159718625276e-06
PLA2G15,Phospholipase A2 group XV,Mental health,X29154.Anxiety or depression today,17203,0.203550805749682,0.0655201647858504,0.0751312827694152,0.331970328729949,0.00189503210579367
PLA2G15,Phospholipase A2 group XV,Mental health,X29166.Frequency of confiding in someone close,16779,-0.133018281400508,0.0516986500662148,-0.234347635530289,-0.0316889272707267,0.0100919637408301
PLA2G15,Phospholipase A2 group XV,Lifestyle factors,X29167#0.Sports and social activities attended in person at least once a week_None of the above,17149,0.0172140114171483,0.00456199323943182,0.0082725046678619,0.0261555181664347,0.000161610523225399
PLA2G15,Phospholipase A2 group XV,Lifestyle factors,X29167#1.Sports and social activities attended in person at least once a week_Sports club or gym or fitness class,17149,-0.0218707448138339,0.00457824411384123,-0.0308441032769627,-0.0128973863507051,1.79311038167772e-06
PLA2G15,Phospholipase A2 group XV,Lifestyle factors,X29167#2.Sports and social activities attended in person at least once a week_Pub or social club,17149,0.000933365378262421,0.00570949687677018,-0.0102572485002071,0.012123979256732,0.870145642066856
PLA2G15,Phospholipase A2 group XV,Lifestyle factors,X29167#3.Sports and social activities attended in person at least once a week_Religious group,17149,-0.0075211041583945,0.00617777476149819,-0.019629542690931,0.00458733437414196,0.223451521424677
PLA2G15,Phospholipase A2 group XV,Lifestyle factors,X29167#4.Sports and social activities attended in person at least once a week_Adult education class,17149,-0.0274469118508823,0.00995678168046571,-0.0469622039445951,-0.00793161975716946,0.00584666787541049
PLA2G15,Phospholipase A2 group XV,Lifestyle factors,X29167#5.Sports and social activities attended in person at least once a week_Other group activity,17149,-0.012057352466853,0.00472078055613964,-0.0213100823568867,-0.00280462257681931,0.0106547970219484
PLA2G15,Phospholipase A2 group XV,Lifestyle factors,X29168#0.Sports and social activities attended virtually at least once a week_None of the above,17146,-0.00210783308564169,0.00513311026519368,-0.0121687292054213,0.00795306303413791,0.681345566455101
PLA2G15,Phospholipase A2 group XV,Lifestyle factors,X29168#1.Sports and social activities attended virtually at least once a week_Sports club or gym or fitness class,17146,-0.0105634589654672,0.00750187474192055,-0.0252671334596315,0.00414021552869707,0.159116877837969
PLA2G15,Phospholipase A2 group XV,Lifestyle factors,X29168#2.Sports and social activities attended virtually at least once a week_Pub or social club,17146,0.0246700019568284,0.011626497789545,0.00188206628932017,0.0474579376243366,0.0338623530998238
PLA2G15,Phospholipase A2 group XV,Lifestyle factors,X29168#3.Sports and social activities attended virtually at least once a week_Religious group,17146,0.00838985982688573,0.0104046604096271,-0.0120032745759834,0.0287829942297548,0.420048831345366
PLA2G15,Phospholipase A2 group XV,Lifestyle factors,X29168#4.Sports and social activities attended virtually at least once a week_Adult education class,17146,-0.0207309713186228,0.0153787587902767,-0.0508733385475652,0.00941139591031957,0.177667746733078
PLA2G15,Phospholipase A2 group XV,Lifestyle factors,X29168#5.Sports and social activities attended virtually at least once a week_Other group activity,17146,0.0062369075074056,0.0073749856479364,-0.00821806436254975,0.020691879377361,0.397740851226133
PLA2G15,Phospholipase A2 group XV,Mental health,X29171.Frequency of feeling 'in tune' with people,16858,-0.130390711565468,0.0636410367110475,-0.255127143519121,-0.0056542796118146,0.0404925950256585
PLA2G15,Phospholipase A2 group XV,Mental health,X29172.Freuency of feeling that lacks companionship,17078,0.166189370069372,0.0578527403395539,0.0527979990038469,0.279580741134898,0.00407575695013892
PLA2G15,Phospholipase A2 group XV,Mental health,X29173.Frequency of feeling left out,16992,0.0975815096683659,0.0602295951863261,-0.0204684968968333,0.215631516233565,0.105216738386971
PLA2G15,Phospholipase A2 group XV,Mental health,X29174.Frequency of feeling isolated from others,17056,0.179816662626908,0.0623262975622318,0.0576571194049341,0.301976205848883,0.00391798744939742
PLA2G15,Phospholipase A2 group XV,Mental health,X29175.Tendency to bounce back quickly after hard times,17181,-0.0957639248888344,0.0512730411704454,-0.196259085582907,0.00473123580523865,0.0618174838958811
PLA2G15,Phospholipase A2 group XV,Mental health,X29176.Ability to make it through stressful events,17181,0.0868953533486266,0.0498818800147316,-0.0108731314802473,0.184663838177501,0.0815224337177148
PLA2G15,Phospholipase A2 group XV,Mental health,X29177.Quick recovery from stressful events,17181,-0.0494557600535505,0.0507726382810263,-0.148970131084362,0.050058610977261,0.330038872179937
PLA2G15,Phospholipase A2 group XV,Mental health,X29178.Hard to snap back when something bad happens,17181,0.0703135305319811,0.0502798150734389,-0.0282349070119591,0.168861968075921,0.161997697043677
PLA2G15,Phospholipase A2 group XV,Mental health,X29179.Comes through difficult times with little trouble,17181,0.00419114484967726,0.0511298386499018,-0.0960233389041303,0.104405628603485,0.934671028174437
PLA2G15,Phospholipase A2 group XV,Mental health,X29180.Tendency to take a long time to get over setbacks,17181,0.0450731028625017,0.0504831708439403,-0.0538739119916213,0.144020117716625,0.371958470956677
PLA2G15,Phospholipase A2 group XV,Mental health,X29181.General happiness,17083,0.101453140987141,0.052450772129158,-0.00135037238600888,0.204256654360291,0.0530983580036256
PLA2G15,Phospholipase A2 group XV,Mental health,X29182.Belief that own life is meaningful,16890,-0.149141812862892,0.0522065610663767,-0.251466672552991,-0.046816953172794,0.00428507192529011
PLA2G15,Phospholipase A2 group XV,Lifestyle factors,X2926.Number of unsuccessful stop-smoking attempts,11481,-0.0213169959022472,0.0570726940978641,-0.133179476334061,0.0905454845295664,0.708778756936445
PLA2G15,Phospholipase A2 group XV,Health and medical history,X2946.Father's age,11252,-0.010190219862703,0.00413716099910042,-0.0182990554209398,-0.00208138430446618,0.0137892274029781
PLA2G15,Phospholipase A2 group XV,Health and medical history,X2966.Age high blood pressure diagnosed,12871,-0.0082706460583794,0.0034518416878945,-0.0150362557666526,-0.00150503635010618,0.0165888566183904
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30000.White blood cell (leukocyte) count,49965,0.0144885263088031,0.00140292820037173,0.0117387870360745,0.0172382655815317,5.61667051234378e-25
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30010.Red blood cell (erythrocyte) count,49966,0.00246822885984942,0.00156705686697824,-0.000603202599427923,0.00553966031912677,0.115245943168683
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30020.Haemoglobin concentration,49966,0.0105454757057453,0.00167663567488176,0.00725926978297704,0.0138316816285135,3.20779015498152e-10
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30030.Haematocrit percentage,49966,0.00797242529086318,0.00163797955251834,0.00476198536792724,0.0111828652137991,1.13517273959224e-06
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30040.Mean corpuscular volume,49966,0.0068586937076686,0.00138495566967071,0.004144180595114,0.0095732068202232,7.35863172166874e-07
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30050.Mean corpuscular haemoglobin,49965,0.00827562655242018,0.00138873215525806,0.00555371152811439,0.010997541576726,2.55288742612723e-09
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30060.Mean corpuscular haemoglobin concentration,49965,0.00168050595419032,0.00135645421993779,-0.000978144316887746,0.00433915622526839,0.215389769244781
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30070.Red blood cell (erythrocyte) distribution width,49966,0.0198222396295544,0.00135246620286927,0.0171714058719306,0.0224730733871781,1.54759398398994e-48
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30080.Platelet count,49966,0.0140296536481799,0.00138442856454856,0.0113161736616647,0.016743133634695,4.12338070449685e-24
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30090.Platelet crit,49966,0.0116651257859404,0.00141494615963771,0.0088918313130505,0.0144384202588303,1.70242319409975e-16
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30100.Mean platelet (thrombocyte) volume,49966,-0.00897934494103133,0.00132976325171804,-0.0115856809143987,-0.00637300896766398,1.46814247117807e-11
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30110.Platelet distribution width,49966,0.00841787463135033,0.00134515038560794,0.00578137987555877,0.0110543693871419,3.93244515992669e-10
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30120.Lymphocyte count,49889,-0.000975690464008829,0.00138213282837731,-0.00368467080762835,0.0017332898796107,0.480234320986354
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30130.Monocyte count,49889,0.0262185933339683,0.00138948440646094,0.0234952038973049,0.0289419827706317,3.85326555819327e-79
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30140.Neutrophill count,49889,0.012296910139987,0.00138729326238947,0.00957781534570361,0.0150160049342703,7.97090327017998e-19
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30150.Eosinophill count,49889,0.00862333336288666,0.0013511105934351,0.00597515659975387,0.0112715101260195,1.75855838109906e-10
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30160.Basophill count,49889,0.140474490262749,0.0308517502217862,0.0800050598280477,0.20094392069745,5.2958277182318e-06
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30170.Nucleated red blood cell count,49889,0.395104532784265,0.141977141344973,0.116829335748117,0.673379729820412,0.00538999401685471
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30180.Lymphocyte percentage,49890,-0.013102108381413,0.00135751647452165,-0.0157628406714755,-0.0104413760913506,5.06257182701644e-22
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30190.Monocyte percentage,49890,0.0184949026523033,0.00137535590057973,0.0157992050871671,0.0211906002174396,3.76429994308318e-41
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30200.Neutrophill percentage,49890,0.00415772056096761,0.00134530385215659,0.00152092501074069,0.00679451611119453,0.0019990027836881
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30210.Eosinophill percentage,49890,0.00402374931923027,0.00133693106034207,0.00140336444095982,0.00664413419750072,0.00261644285548958
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30220.Basophill percentage,49890,0.00136135521989459,0.00133154872897073,-0.00124848028888805,0.00397119072867722,0.306603756682753
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30230.Nucleated red blood cell percentage,49888,0.394154991367386,0.14218486960465,0.115472646942271,0.6728373357925,0.00557113814311295
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30240.Reticulocyte percentage,49092,0.033803067281113,0.00142725980420644,0.0310056380648684,0.0366004964973577,2.6079089745186e-123
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30250.Reticulocyte count,49092,0.0343634498275591,0.00145805994333409,0.0315056523386242,0.0372212473164939,3.93448095741971e-122
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30260.Mean reticulocyte volume,49092,0.0134279659266199,0.00136620189776085,0.0107502102070086,0.0161057216462311,8.89250715622063e-23
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30270.Mean sphered cell volume,49092,0.00722102793134981,0.00137836044905262,0.00451944145120667,0.00992261441149294,1.62243222617346e-07
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30280.Immature reticulocyte fraction,49092,0.0239315884285785,0.00142912377566872,0.0211305058282678,0.0267326710288892,9.10742207268289e-63
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30290.High light scatter reticulocyte percentage,49092,0.0367843033444212,0.0014561526561777,0.0339302441383129,0.0396383625505295,6.69736900095455e-140
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30300.High light scatter reticulocyte count,49092,0.0375064978745697,0.00147839408442037,0.0346088454691057,0.0404041502800336,4.4359610770757e-141
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30500.Microalbumin in urine,16227,0.0269318616720592,0.00245713385534802,0.022115879315577,0.0317478440285413,7.39632117729771e-28
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30510.Creatinine (enzymatic) in urine,50078,-0.00267349322902061,0.00145174511137128,-0.00551891364730833,0.000171927189267106,0.0655436834541477
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30520.Potassium in urine,49977,-0.00297572743110974,0.00135328393271018,-0.00562816393922168,-0.000323290922997787,0.0278900522968565
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30530.Sodium in urine,49960,0.00129974502546915,0.00141305428477337,-0.00146984137268666,0.00406933142362496,0.357675180766116
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30600.Albumin,45021,-0.00742260509637212,0.00145360316777053,-0.0102716673052024,-0.00457354288754188,3.29779176804052e-07
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30610.Alkaline phosphatase,49138,0.0324845570347588,0.00138860081700296,0.029762899433433,0.0352062146360846,2.25979166897035e-120
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30620.Alanine aminotransferase,49132,0.0551966241532202,0.00145653460209612,0.0523418163331118,0.0580514319733286,1.69144345846598e-308
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30630.Apolipoprotein A,44742,-0.0169985891470813,0.001592201939315,-0.0201193049481387,-0.0138778733460239,1.41690117381266e-26
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30640.Apolipoprotein B,48875,0.000326272182600531,0.0013509309566554,-0.00232155249244406,0.00297409685764512,0.80915580528663
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30650.Aspartate aminotransferase,48984,0.062272089673033,0.00137379010232938,0.0595794610724674,0.0649647182735986,0
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30660.Direct bilirubin,41699,0.0127287967724035,0.00153548119635004,0.00971925362755742,0.0157383399172496,1.1681229525607e-16
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30670.Urea,49115,-0.0457911323088592,0.00141338983320584,-0.0485613763819426,-0.0430208882357757,7.44722246756193e-228
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30680.Calcium,45018,0.00183635777693565,0.00141068535747566,-0.000928585523716639,0.00460130107758794,0.193008981655142
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30690.Cholesterol,49149,-0.0077592822956944,0.00137110854451113,-0.0104466550429362,-0.00507190954845258,1.52986659752401e-08
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30700.Creatinine,49129,-0.0230234506746137,0.00165407956076134,-0.0262654466137059,-0.0197814547355214,5.87182385399194e-44
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30710.C-reactive protein,49003,0.040179473082319,0.00150203919584942,0.0372354762584541,0.0431234699061838,1.6564733691877e-156
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30720.Cystatin C,49149,0.0533237897302707,0.00156574967023016,0.0502549203766196,0.0563926590839219,2.78852071357655e-251
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30730.Gamma glutamyltransferase,49128,0.0607080203969847,0.00147824707564725,0.0578106561287161,0.0636053846652534,0
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30740.Glucose,44967,0.0214218891664424,0.00144752536359908,0.0185847394537882,0.0242590388790967,1.9451009262515e-49
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30750.Glycated haemoglobin (HbA1c),48875,0.0152190326743835,0.00146755184604691,0.0123426310561316,0.0180954342926355,3.59251731106224e-25
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30760.HDL cholesterol,44992,-0.034233470902201,0.00165607589525001,-0.037479379656891,-0.030987562147511,1.72492368710849e-94
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30770.IGF-1,48892,-0.0482486516452499,0.00139791688745452,-0.0509885687446608,-0.0455087345458391,6.18459898452943e-258
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30780.LDL direct,49038,-0.00650852991644556,0.00135315068733088,-0.00916070526361408,-0.00385635456927704,1.51447737485623e-06
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30790.Lipoprotein A,39272,-0.0113911643275113,0.00149920348062751,-0.0143296031495412,-0.00845272550548136,3.07068987757255e-14
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30810.Phosphate,44918,-0.00879554810226295,0.00146088278520832,-0.0116588783612712,-0.00593221784325465,1.75000358418724e-09
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30830.SHBG,44595,0.0283365338214811,0.00167569681865616,0.0250521680569151,0.0316208995860472,5.98323825033039e-64
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30840.Total bilirubin,48951,0.000883958359333943,0.00143598703541635,-0.0019305762300821,0.00369849294874999,0.538177623914543
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30850.Testosterone,44392,0.0167485460692397,0.00235159095662312,0.0121394277942584,0.021357664344221,1.07813565477376e-12
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30860.Total protein,44984,0.032863214170427,0.00142309600211912,0.0300739460062735,0.0356524823345805,2.64311982823009e-117
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30870.Triglycerides,49110,0.0316502225283217,0.0014658699424214,0.0287771174411757,0.0345233276154676,6.52499264461183e-103
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30880.Urate,49080,0.00925415530785974,0.00169269931296822,0.00593646465444203,0.0125718459612774,4.59683974695035e-08
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30890.Vitamin D,46927,-0.0255953671394143,0.00152173165893426,-0.0285779611909255,-0.0226127730879032,2.67614965927346e-63
PLA2G15,Phospholipase A2 group XV,Physical measures,X3137.Number of measurements made,46722,0.0433738492163145,0.0358251634444252,-0.026843471134759,0.113591169567388,0.226013063109366
PLA2G15,Phospholipase A2 group XV,Physical measures,X3143.Ankle spacing width,29223,0.0150751685361262,0.00240581219698491,0.0103597766300358,0.0197905604422167,3.75256094769904e-10
PLA2G15,Phospholipase A2 group XV,Physical measures,"X3144.Heel Broadband ultrasound attenuation, direct entry",29221,-0.00941202968896031,0.00185357126976686,-0.0130450293777033,-0.00577903000021727,3.84212615846988e-07
PLA2G15,Phospholipase A2 group XV,Physical measures,X3146.Speed of sound through heel,29223,-0.013045986686321,0.00179050473862408,-0.0165553759740242,-0.00953659739861777,3.26873668115776e-13
PLA2G15,Phospholipase A2 group XV,Physical measures,"X3147.Heel quantitative ultrasound index (QUI), direct entry",29223,-0.0122483919239013,0.00180911332317471,-0.0157942540373238,-0.00870252981047891,1.30870902011917e-11
PLA2G15,Phospholipase A2 group XV,Physical measures,X3148.Heel bone mineral density (BMD),29202,-0.0126461047111987,0.00181062105896195,-0.0161949219867641,-0.00909728743563327,2.92198298250597e-12
PLA2G15,Phospholipase A2 group XV,Health and medical history,X3526.Mother's age at death,30734,-0.00638211664488374,0.00179255892859589,-0.00989553214493169,-0.00286870114483579,0.000370936175265784
PLA2G15,Phospholipase A2 group XV,Health and medical history,X3581.Age at menopause (last menstrual period),15914,-0.0109415118909625,0.00232608601357401,-0.0155006404775676,-0.00638238330435745,2.57473551354324e-06
PLA2G15,Phospholipase A2 group XV,Health and medical history,"X3761.Age hay fever, rhinitis or eczema diagnosed",10153,-0.000414369437375435,0.0029994085157688,-0.00629321012828229,0.00546447125353142,0.890124310502378
PLA2G15,Phospholipase A2 group XV,Physical measures,X4100.Ankle spacing width (left),16575,0.0131131359295725,0.00323020165192543,0.00678194069179867,0.0194443311673464,4.93952068788102e-05
PLA2G15,Phospholipase A2 group XV,Physical measures,X4101.Heel broadband ultrasound attenuation (left),16571,-0.0132516530084196,0.00248528816321973,-0.0181228178083302,-0.00838048820850891,9.83905490189014e-08
PLA2G15,Phospholipase A2 group XV,Physical measures,X4103.Speed of sound through heel (left),16575,-0.0190347479925171,0.00240046508704229,-0.0237396595631199,-0.0143298364219142,2.33762682527771e-15
PLA2G15,Phospholipase A2 group XV,Physical measures,"X4104.Heel quantitative ultrasound index (QUI), direct entry (left)",16575,-0.017613881001839,0.00242623882266421,-0.0223693090942609,-0.0128584529094172,4.05022928406626e-13
PLA2G15,Phospholipase A2 group XV,Physical measures,X4105.Heel bone mineral density (BMD) (left),16562,-0.0170576361784795,0.00242928924878518,-0.0218190431060985,-0.0122962292508605,2.27772645203725e-12
PLA2G15,Phospholipase A2 group XV,Physical measures,"X4106.Heel bone mineral density (BMD) T-score, automated (left)",16575,-0.0176123073147796,0.00242624594213485,-0.0223677493613639,-0.0128568652681953,4.07027277543451e-13
PLA2G15,Phospholipase A2 group XV,Physical measures,X4119.Ankle spacing width (right),16567,0.0135293598669976,0.00317937790323776,0.00729777917665159,0.0197609405573436,2.09871969434998e-05
PLA2G15,Phospholipase A2 group XV,Physical measures,X4120.Heel broadband ultrasound attenuation (right),16566,-0.0139064407561928,0.00249566557422252,-0.0187979452816689,-0.00901493623071667,2.55408953592935e-08
PLA2G15,Phospholipase A2 group XV,Physical measures,X4122.Speed of sound through heel (right),16567,-0.0177910484869259,0.00240589861794291,-0.022506609778094,-0.0130754871957578,1.48433507695346e-13
PLA2G15,Phospholipase A2 group XV,Physical measures,"X4123.Heel quantitative ultrasound index (QUI), direct entry (right)",16567,-0.0168321812505519,0.00243335222268936,-0.021601551607023,-0.0120628108940807,4.77242668289968e-12
PLA2G15,Phospholipase A2 group XV,Physical measures,X4124.Heel bone mineral density (BMD) (right),16552,-0.0162706422171542,0.00243724256539767,-0.0210476376453336,-0.0114936467889748,2.53636284124748e-11
PLA2G15,Phospholipase A2 group XV,Physical measures,"X4125.Heel bone mineral density (BMD) T-score, automated (right)",16567,-0.0168321298847856,0.00243335390602625,-0.0216015035405971,-0.0120627562289742,4.77329625828413e-12
PLA2G15,Phospholipase A2 group XV,Physical measures,X4194.Pulse rate,17223,0.0365480697392527,0.00230697819745315,0.0320263924722445,0.0410697470062609,3.95529240024928e-56
PLA2G15,Phospholipase A2 group XV,Physical measures,X4195.Pulse wave reflection index,17223,-0.00928587161183227,0.00238328824647498,-0.0139571165749232,-0.00461462664874131,9.80658577772207e-05
PLA2G15,Phospholipase A2 group XV,Physical measures,X4196.Pulse wave peak to peak time,17213,-0.0152815006617661,0.00236546706459844,-0.0199178161083791,-0.0106451852151532,1.07337136549033e-10
PLA2G15,Phospholipase A2 group XV,Physical measures,X4198.Position of the pulse wave peak,17223,0.0223883925036054,0.00238893439564649,0.0177060810881383,0.0270707039190726,8.00041086974674e-21
PLA2G15,Phospholipase A2 group XV,Physical measures,X4199.Position of pulse wave notch,17223,0.0249167529564495,0.00231428342529427,0.0203807574428727,0.0294527484700263,6.03716252097583e-27
PLA2G15,Phospholipase A2 group XV,Physical measures,X4200.Position of the shoulder on the pulse waveform,17223,0.0245579883138386,0.00240008657712362,0.0198538186226763,0.0292621580050009,1.67330104990415e-24
PLA2G15,Phospholipase A2 group XV,Physical measures,X4269.Number of triplets attempted (left),16898,-0.0583041305428782,0.149249273279983,-0.350832706171645,0.234224445085889,0.696061380400894
PLA2G15,Phospholipase A2 group XV,Physical measures,X4270.Volume level set by participant (left),16719,0.0680471661605686,0.0478624268662797,-0.0257631904973397,0.161857522818477,0.155125030741159
PLA2G15,Phospholipase A2 group XV,Physical measures,X4276.Number of triplets attempted (right),16904,-0.0945621932169748,0.144961943089217,-0.378687601671839,0.18956321523789,0.514200892899922
PLA2G15,Phospholipase A2 group XV,Physical measures,X4277.Volume level set by participant (right),16709,0.0716109851782105,0.0474875149141877,-0.0214645440535974,0.164686514410018,0.131574462092304
PLA2G15,Phospholipase A2 group XV,Cognitive function,X4288.Time to answer,17263,-0.00363376406677863,0.00267625891613766,-0.00887923154240844,0.00161170340885117,0.174552066619885
PLA2G15,Phospholipase A2 group XV,Cognitive function,X4290.Duration screen displayed,17263,0.00662018597484772,0.0024486704787155,0.00182079183656535,0.0114195801131301,0.00686633592196485
PLA2G15,Phospholipase A2 group XV,Physical measures,X46.Hand grip strength (left),51395,-0.0284325466497959,0.00190230929793852,-0.0321610728737554,-0.0247040204258364,2.10102554395997e-50
PLA2G15,Phospholipase A2 group XV,Physical measures,X47.Hand grip strength (right),51399,-0.0264679751804052,0.00188601440368495,-0.0301645634116277,-0.0227713869491826,1.17074960965101e-44
PLA2G15,Phospholipase A2 group XV,Physical measures,X48.Waist circumference,51543,0.048581570450402,0.00293954429527167,0.0428200636316696,0.0543430772691345,3.37805494813802e-61
PLA2G15,Phospholipase A2 group XV,Health and medical history,X4803.Tinnitus,16950,0.00890347684350847,0.0557387869841328,-0.100344545645392,0.118151499332409,0.873091144677066
PLA2G15,Phospholipase A2 group XV,Working and living environment,X4825.Noisy workplace,17164,0.200882777362137,0.0618639827255073,0.0796293712201426,0.322136183504131,0.00116783302456192
PLA2G15,Phospholipase A2 group XV,Working and living environment,X4836.Loud music exposure frequency,17059,0.0939185361390829,0.0789212001657705,-0.0607670161858273,0.248604088463993,0.234051474882176
PLA2G15,Phospholipase A2 group XV,Physical measures,X49.Hip circumference,51534,-0.0216213931393396,0.00235700479267642,-0.0262411225329854,-0.0170016637456938,4.75382717007562e-20
PLA2G15,Phospholipase A2 group XV,Physical measures,X50.Standing height,51491,0.0016342481581817,0.00187307957559471,-0.00203698780998393,0.00530548412634734,0.382943746937873
PLA2G15,Phospholipase A2 group XV,Health and medical history,X5057.Number of older siblings,15145,0.0429584586498371,0.0506787867389178,-0.0563719633584418,0.142288880658116,0.396639897219749
PLA2G15,Phospholipase A2 group XV,Physical measures,X51.Seated height,51257,-0.000169229598767099,0.00174147493806661,-0.00358252047737765,0.00324406127984345,0.922586993332028
PLA2G15,Phospholipase A2 group XV,Eye measures,X5181.Ever had eye surgery,11641,0.0523879147850476,0.115145089326676,-0.173296460295237,0.278072289865332,0.649137109268989
PLA2G15,Phospholipase A2 group XV,Eye measures,X5186.Duration visual-acuity screen displayed (right),11613,0.00359468949763644,0.00281805232251723,-0.00192869305449734,0.00911807204977021,0.202124764450488
PLA2G15,Phospholipase A2 group XV,Eye measures,X5188.Duration visual-acuity screen displayed (left),11611,0.00373874284830263,0.00284248353530421,-0.00183252488089362,0.00931001057749889,0.188432236056828
PLA2G15,Phospholipase A2 group XV,Eye measures,X5190.Duration at which refractometer first shown (right),11483,0.00125792124087564,0.00286012015579609,-0.00434791426448469,0.00686375674623596,0.660080024490933
PLA2G15,Phospholipase A2 group XV,Eye measures,X5193.Duration at which refractometer first shown (left),11480,0.00197806603257319,0.00287685570077787,-0.00366057114095142,0.00761670320609781,0.491731741881214
PLA2G15,Phospholipase A2 group XV,Eye measures,"X5199.logMAR, initial (right)",11572,0.109836962062439,0.0602303698097982,-0.00821456276476579,0.227888486889643,0.0682362225584115
PLA2G15,Phospholipase A2 group XV,Eye measures,X5200.Final number of letters displayed (right),11572,0.0422684320839455,0.402852702000072,-0.747322863836197,0.831859728004087,0.916438890758899
PLA2G15,Phospholipase A2 group XV,Eye measures,"X5201.logMAR, final (right)",11460,0.0078145749651593,0.00286999327465809,0.00218938814682945,0.0134397617834891,0.00648185543064085
PLA2G15,Phospholipase A2 group XV,Eye measures,X5202.Number of rounds to result (right),11572,-0.0299897996677048,0.0566748361853136,-0.141072478590919,0.0810928792555098,0.5967077750736
PLA2G15,Phospholipase A2 group XV,Eye measures,"X5206.logMAR, initial (left)",11565,0.133247710909513,0.0602685899217407,0.0151212746629013,0.251374147156125,0.0270624130035352
PLA2G15,Phospholipase A2 group XV,Eye measures,X5207.Final number of letters displayed (left),11565,-0.497528970157341,0.348288396791646,-1.18017422786897,0.185116287554284,0.153175867283322
PLA2G15,Phospholipase A2 group XV,Eye measures,"X5208.logMAR, final (left)",11454,0.00687743118790164,0.00287005018839867,0.00125213281864025,0.012502729557163,0.0165785900936988
PLA2G15,Phospholipase A2 group XV,Eye measures,X5209.Number of rounds to result (left),11559,0.0216690857823106,0.0565307903997414,-0.0891312634011825,0.132469434965804,0.701493468629018
PLA2G15,Phospholipase A2 group XV,Eye measures,"X5254.Intra-ocular pressure, corneal-compensated (right)",11066,0.00460026943710631,0.00284781982015192,-0.000981457410391443,0.0101819962846041,0.106260145136258
PLA2G15,Phospholipase A2 group XV,Eye measures,"X5255.Intra-ocular pressure, Goldmann-correlated (right)",11066,0.00916952121500311,0.00283420606531306,0.00361447732698951,0.0147245651030167,0.00121870318555507
PLA2G15,Phospholipase A2 group XV,Eye measures,X5256.Corneal hysteresis (right),11066,0.0050184915797632,0.00287435501525327,-0.000615244250133213,0.0106522274096596,0.0808467337181827
PLA2G15,Phospholipase A2 group XV,Eye measures,X5257.Corneal resistance factor (right),11066,0.00919012379185976,0.0028556266642143,0.00359309552999975,0.0147871520537198,0.00129346939655418
PLA2G15,Phospholipase A2 group XV,Eye measures,"X5262.Intra-ocular pressure, corneal-compensated (left)",11038,0.00120440079824302,0.00285521182984331,-0.00439181438824986,0.00680061598473591,0.673160708719391
PLA2G15,Phospholipase A2 group XV,Eye measures,"X5263.Intra-ocular pressure, Goldmann-correlated (left)",11038,0.00579973369980657,0.00283080445162091,0.000251356974629581,0.0113481104249836,0.040505938862468
PLA2G15,Phospholipase A2 group XV,Eye measures,X5264.Corneal hysteresis (left),11038,0.00769413048247883,0.00288077869021069,0.00204780424966588,0.0133404567152918,0.00757703059207843
PLA2G15,Phospholipase A2 group XV,Eye measures,X5265.Corneal resistance factor (left),11038,0.00951611459747815,0.00285320095003292,0.00392384073541363,0.0151083884595427,0.000855066489053743
PLA2G15,Phospholipase A2 group XV,Lifestyle factors,X5364.Average weekly intake of other alcoholic drinks,11536,0.27769207806115,0.256130827066463,-0.224324342989118,0.779708499111418,0.278307411537812
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,"X6144#1.Never eat eggs, dairy, wheat, sugar_Eggs or foods containing eggs",51380,0.033974979677099,0.00760542264686533,0.019068351289243,0.0488816080649551,7.94171579417366e-06
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,"X6144#2.Never eat eggs, dairy, wheat, sugar_Dairy products",51380,0.0257477624733385,0.00827759145067434,0.00952368323001677,0.0419718417166602,0.00186849097906685
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,"X6144#3.Never eat eggs, dairy, wheat, sugar_Wheat products",51380,0.0392081693723165,0.00790413942707561,0.0237160560952483,0.0547002826493847,7.05504665537097e-07
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,"X6144#4.Never eat eggs, dairy, wheat, sugar_Sugar or foods or drinks containing sugar",51380,-0.00862436953519158,0.00338628356725364,-0.0152614853270087,-0.00198725374337444,0.0108727834923282
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,"X6144#5.Never eat eggs, dairy, wheat, sugar_I eat all of the above",51380,-0.00319564216342955,0.00311645227815192,-0.00930388862860732,0.00291260430174821,0.305174474466747
PLA2G15,Phospholipase A2 group XV,Mental health,"X6145#3.Illness, injury, bereavement, stress in last 2 years_Death of a close relative",23225,-0.0199851666027355,0.00397565578533168,-0.0277774519419856,-0.0121928812634854,5.02216647001812e-07
PLA2G15,Phospholipase A2 group XV,Mental health,"X6145#4.Illness, injury, bereavement, stress in last 2 years_Death of a spouse or partner",23225,0.00742973182461615,0.010831020406077,-0.0137990681712948,0.0286585318205271,0.492740231309512
PLA2G15,Phospholipase A2 group XV,Mental health,"X6145#5.Illness, injury, bereavement, stress in last 2 years_Marital separation or divorce",23225,-0.00925780317762032,0.00771825005534284,-0.0243855732860923,0.00586996693085164,0.230357799962386
PLA2G15,Phospholipase A2 group XV,Mental health,"X6145#6.Illness, injury, bereavement, stress in last 2 years_Financial difficulties",23225,0.0147035331177624,0.0047067389477546,0.00547832478016338,0.0239287414553614,0.00178671225075448
PLA2G15,Phospholipase A2 group XV,Eye measures,X6147#1.Reason for glasses or contact lenses_For short-sightedness,51540,-0.000781065062280266,0.00521706179004422,-0.0110065061707669,0.0094443760462064,0.880991169846699
PLA2G15,Phospholipase A2 group XV,Eye measures,X6147#2.Reason for glasses or contact lenses_For long-sightedness,51540,0.0109536043983149,0.00671259483757531,-0.0022030814833327,0.0241102902799625,0.102727983069509
PLA2G15,Phospholipase A2 group XV,Eye measures,X6147#3.Reason for glasses or contact lenses_For just reading or near work as you are getting older (called 'presbyopia'),51540,-0.00289778735954677,0.00514926076135891,-0.0129903384518102,0.00719476373271668,0.573602175329043
PLA2G15,Phospholipase A2 group XV,Eye measures,X6147#4.Reason for glasses or contact lenses_For 'astigmatism',51540,-0.0158980168348651,0.00846339223413635,-0.0324862656137723,0.000690231944042153,0.0603259557859009
PLA2G15,Phospholipase A2 group XV,Eye measures,X6147#5.Reason for glasses or contact lenses_For a 'squint' or 'turn' in an eye since childhood (called 'strabismus'),51540,0.00873027035325348,0.0205626549774017,-0.0315725334024539,0.0490330741089609,0.671152508916939
PLA2G15,Phospholipase A2 group XV,Eye measures,X6147#6.Reason for glasses or contact lenses_For a 'lazy' eye or an eye with poor vision since childhood (called 'amblyopia'),51540,0.0133811914651162,0.0142799422631425,-0.0146074953706431,0.0413698783008756,0.348731051233268
PLA2G15,Phospholipase A2 group XV,Eye measures,X6147#7.Reason for glasses or contact lenses_Other eye condition,51540,0.0803515636186728,0.0224438311405661,0.0363616545831633,0.124341472654182,0.000343754648683868
PLA2G15,Phospholipase A2 group XV,Health and medical history,X6149#1.Mouth or teeth dental problems_Mouth ulcers,51379,0.0120332011751509,0.00432745195835161,0.00355139533678177,0.0205150070135201,0.00542671626227381
PLA2G15,Phospholipase A2 group XV,Health and medical history,X6149#2.Mouth or teeth dental problems_Painful gums,51379,0.0237174988087548,0.00739315922812969,0.00922690672162061,0.038208090895889,0.00133728103993407
PLA2G15,Phospholipase A2 group XV,Health and medical history,X6149#3.Mouth or teeth dental problems_Bleeding gums,51379,0.0061886433399665,0.00388604725284072,-0.00142800927560132,0.0138052959555343,0.11127202293047
PLA2G15,Phospholipase A2 group XV,Health and medical history,X6149#4.Mouth or teeth dental problems_Loose teeth,51379,0.0382143234148846,0.00650305961448892,0.0254683265704863,0.0509603202592829,4.21964275809589e-09
PLA2G15,Phospholipase A2 group XV,Health and medical history,X6149#5.Mouth or teeth dental problems_Toothache,51379,0.0229893396894438,0.00645649640477393,0.0103346067360869,0.0356440726428007,0.000370268553090114
PLA2G15,Phospholipase A2 group XV,Health and medical history,X6149#6.Mouth or teeth dental problems_Dentures,51379,0.0460511742433196,0.00362262906391076,0.0389508212780545,0.0531515272085847,5.76055917713561e-37
PLA2G15,Phospholipase A2 group XV,Health and medical history,X6150#1.Vascular or heart problems diagnosed by doctor_Heart attack,15990,0.0169952982413679,0.00900595807031888,-0.000656379576457103,0.0346469760591929,0.0591626787748893
PLA2G15,Phospholipase A2 group XV,Health and medical history,X6150#2.Vascular or heart problems diagnosed by doctor_Angina,15990,0.00864553049152549,0.00775594675506118,-0.00655612514839442,0.0238471861314454,0.264997060171454
PLA2G15,Phospholipase A2 group XV,Health and medical history,X6150#3.Vascular or heart problems diagnosed by doctor_Stroke,15990,0.0336784247556928,0.0107372145232988,0.0126334842900271,0.0547233652213585,0.00171225159268691
PLA2G15,Phospholipase A2 group XV,Health and medical history,X6150#4.Vascular or heart problems diagnosed by doctor_High blood pressure,15990,0.00248336209237999,0.0085346440839456,-0.0142445403121534,0.0192112644969134,0.771074751968385
PLA2G15,Phospholipase A2 group XV,Health and medical history,X6151#1.Fractured bone site(s)_Ankle,51325,0.00781279850019336,0.010960282678174,-0.0136693555490277,0.0292949525494144,0.475955318856313
PLA2G15,Phospholipase A2 group XV,Health and medical history,X6151#2.Fractured bone site(s)_Leg,51325,-0.00618246976085332,0.0163247362160725,-0.0381789527443554,0.0258140132226488,0.704898929057177
PLA2G15,Phospholipase A2 group XV,Health and medical history,X6151#3.Fractured bone site(s)_Hip,51325,0.0630311821353112,0.0287449763026734,0.00669102858207139,0.119371335688551,0.0283282760445349
PLA2G15,Phospholipase A2 group XV,Health and medical history,X6151#4.Fractured bone site(s)_Spine,51325,0.0462220376631744,0.0280846778906829,-0.00882393100256419,0.101268006328913,0.0998090519232836
PLA2G15,Phospholipase A2 group XV,Health and medical history,X6151#5.Fractured bone site(s)_Wrist,51325,0.00546152902106957,0.00954644884067006,-0.0132495107066437,0.0241725687487829,0.567256335286407
PLA2G15,Phospholipase A2 group XV,Health and medical history,X6151#6.Fractured bone site(s)_Arm,51325,0.0252878729985476,0.012720942082564,0.00035482651672224,0.050220919480373,0.046828819366775
PLA2G15,Phospholipase A2 group XV,Health and medical history,X6151#7.Fractured bone site(s)_Other bones,51325,0.00845669930507104,0.00588304880523895,-0.00307407635319729,0.0199874749633394,0.150590920353968
PLA2G15,Phospholipase A2 group XV,Health and medical history,"X6152#5.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Blood clot in the leg (DVT)",16634,0.0383744471957492,0.00931826894401168,0.0201106400654863,0.0566382543260121,3.836980408966e-05
PLA2G15,Phospholipase A2 group XV,Health and medical history,"X6152#6.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Emphysema or chronic bronchitis",16634,0.0578327166150688,0.0100553163946702,0.0381242964815153,0.0775411367486224,9.00325339536514e-09
PLA2G15,Phospholipase A2 group XV,Health and medical history,"X6152#7.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Blood clot in the lung",16634,0.0100267807230272,0.0136285265633763,-0.0166851313411903,0.0367386927872447,0.461911446297426
PLA2G15,Phospholipase A2 group XV,Health and medical history,"X6152#8.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Asthma",16634,0.00617171547864707,0.0047960025269023,-0.00322844947408144,0.0155718804313756,0.198165979127392
PLA2G15,Phospholipase A2 group XV,Health and medical history,"X6154#1.Medication for pain relief, constipation, heartburn_Aspirin",23360,-0.00390554778492715,0.00457964629588843,-0.0128816545248685,0.00507055895501417,0.393775893656141
PLA2G15,Phospholipase A2 group XV,Health and medical history,"X6154#2.Medication for pain relief, constipation, heartburn_Ibuprofen",23360,-0.0137911572109784,0.00446754640983899,-0.0225475481742628,-0.005034766247694,0.00202448585653465
PLA2G15,Phospholipase A2 group XV,Health and medical history,"X6154#3.Medication for pain relief, constipation, heartburn_Paracetamol",23360,0.00416713746318994,0.00408478272369988,-0.00383903667526182,0.0121733116016417,0.307662515176544
PLA2G15,Phospholipase A2 group XV,Health and medical history,"X6154#4.Medication for pain relief, constipation, heartburn_Ranitidine",23361,0.0155895756590522,0.00967426453143985,-0.00337198282256993,0.0345511341406743,0.107095597681748
PLA2G15,Phospholipase A2 group XV,Health and medical history,"X6154#5.Medication for pain relief, constipation, heartburn_Omeprazole",23361,0.0640619299459188,0.00578336785780248,0.052726528944626,0.0753973309472117,1.91145154585521e-28
PLA2G15,Phospholipase A2 group XV,Health and medical history,"X6154#6.Medication for pain relief, constipation, heartburn_Laxatives",23361,0.00217771891451013,0.00778486209764517,-0.0130806107968744,0.0174360486258947,0.779681279901001
PLA2G15,Phospholipase A2 group XV,Health and medical history,X6155#1.Vitamin and mineral supplements_Vitamin A,51379,-0.0168818143666447,0.00909115042969066,-0.0347004692088384,0.000936840475549001,0.0633239480531462
PLA2G15,Phospholipase A2 group XV,Health and medical history,X6155#2.Vitamin and mineral supplements_Vitamin B,51379,0.0145126087457012,0.00637932650752827,0.00200912879094583,0.0270160887004566,0.022913408907358
PLA2G15,Phospholipase A2 group XV,Health and medical history,X6155#3.Vitamin and mineral supplements_Vitamin C,51379,-0.00636120809375037,0.0176205952113713,-0.0408975747080382,0.0281751585205374,0.718093582827341
PLA2G15,Phospholipase A2 group XV,Health and medical history,X6155#4.Vitamin and mineral supplements_Vitamin D,51379,-0.00876376739325622,0.00654907926961117,-0.0215999627616941,0.00407242797518168,0.180847647153174
PLA2G15,Phospholipase A2 group XV,Health and medical history,X6155#5.Vitamin and mineral supplements_Vitamin E,51379,-0.0148566987704943,0.00746688591718637,-0.0294917951681796,-0.000221602372809047,0.0466317090786163
PLA2G15,Phospholipase A2 group XV,Health and medical history,X6155#6.Vitamin and mineral supplements_Folic acid or Folate (Vit B9),51379,0.0440656264482568,0.00858207239859023,0.02724476454702,0.0608864883494937,2.8375363168024e-07
PLA2G15,Phospholipase A2 group XV,Health and medical history,X6155#7.Vitamin and mineral supplements_Multivitamins + or - minerals,51379,0.00559519833253313,0.00282069787148448,6.66305044235574e-05,0.0111237661606427,0.0473033108036092
PLA2G15,Phospholipase A2 group XV,Lifestyle factors,X6157#1.Why stopped smoking_Illness or ill health,10017,0.0336392510396688,0.00827784321347103,0.0174146783412656,0.049863823738072,4.8655586655563e-05
PLA2G15,Phospholipase A2 group XV,Lifestyle factors,X6157#2.Why stopped smoking_Doctor's advice,10017,0.0635496359900436,0.010275777630266,0.0434091118347222,0.0836901601453649,6.47718656466196e-10
PLA2G15,Phospholipase A2 group XV,Lifestyle factors,X6157#3.Why stopped smoking_Health precaution,10017,-0.0390000588433795,0.00731313015868624,-0.0533337939544045,-0.0246663237323544,9.87745732013352e-08
PLA2G15,Phospholipase A2 group XV,Lifestyle factors,X6157#4.Why stopped smoking_Financial reasons,10017,-0.00333212633238331,0.00655355887453098,-0.016177101726464,0.00951284906169741,0.611152290240626
PLA2G15,Phospholipase A2 group XV,Health and medical history,X6159#1.Pain type(s) experienced in last month_Headache,51616,0.013132319392355,0.00330536211029349,0.0066538096561798,0.0196108291285303,7.10589509553578e-05
PLA2G15,Phospholipase A2 group XV,Health and medical history,X6159#2.Pain type(s) experienced in last month_Facial pain,51616,0.0256243866012072,0.00953409868960879,0.00693755316957394,0.0443112200328404,0.00719783514108496
PLA2G15,Phospholipase A2 group XV,Health and medical history,X6159#3.Pain type(s) experienced in last month_Neck or shoulder pain,51616,0.0098558236813977,0.00308850481627027,0.00380235424150798,0.0159092931212874,0.00141801798477794
PLA2G15,Phospholipase A2 group XV,Health and medical history,X6159#4.Pain type(s) experienced in last month_Back pain,51616,0.00682686356111111,0.0029899919343517,0.000966479369781765,0.0126872477524404,0.0224203921906628
PLA2G15,Phospholipase A2 group XV,Health and medical history,X6159#5.Pain type(s) experienced in last month_Stomach or abdominal pain,51616,0.0496349956916443,0.00461661900858353,0.0405864224348206,0.058683568948468,6.23535375843549e-27
PLA2G15,Phospholipase A2 group XV,Health and medical history,X6159#6.Pain type(s) experienced in last month_Hip pain,51616,0.0128555355075051,0.00412385624007497,0.00477277727695817,0.020938293738052,0.0018258016220621
PLA2G15,Phospholipase A2 group XV,Health and medical history,X6159#7.Pain type(s) experienced in last month_Knee pain,51616,0.00244004761963009,0.00321264115451436,-0.00385672904321804,0.00873682428247823,0.447548298308685
PLA2G15,Phospholipase A2 group XV,Health and medical history,X6159#8.Pain type(s) experienced in last month_Pain all over the body,51616,0.0740872914932067,0.00944814755264516,0.0555689222900222,0.0926056606963912,4.53824164967086e-15
PLA2G15,Phospholipase A2 group XV,Lifestyle factors,X6160#1.Leisure or social activities_Sports club or gym,35754,-0.0357034555278532,0.00321763807539085,-0.0420100261556193,-0.0293968849000872,1.45798903789159e-28
PLA2G15,Phospholipase A2 group XV,Lifestyle factors,X6160#2.Leisure or social activities_Pub or social club,35754,0.0189787185960166,0.00336557310944719,0.0123821953015001,0.0255752418905331,1.72254702852606e-08
PLA2G15,Phospholipase A2 group XV,Lifestyle factors,X6160#3.Leisure or social activities_Religious group,35754,0.00733783990477981,0.00379387846782183,-9.81618921509749e-05,0.0147738417017106,0.0531054922939349
PLA2G15,Phospholipase A2 group XV,Lifestyle factors,X6160#4.Leisure or social activities_Adult education class,35755,-0.0222654110217048,0.00519322525153165,-0.0324441325147068,-0.0120866895287028,1.8125352653569e-05
PLA2G15,Phospholipase A2 group XV,Lifestyle factors,X6160#5.Leisure or social activities_Other group activity,35755,-0.00970444858477117,0.00340665729130649,-0.0163814968757319,-0.00302740029381044,0.0043927205245103
PLA2G15,Phospholipase A2 group XV,Physical activities,X6162#1.Types of transport used (excluding work)_Car or motor vehicle,51140,-0.00821526587802514,0.00332415351259947,-0.0147306067627201,-0.00169992499333018,0.0134622854148369
PLA2G15,Phospholipase A2 group XV,Physical activities,X6162#2.Types of transport used (excluding work)_Walk,51140,-0.0120341220536078,0.00264579642755464,-0.0172198830516149,-0.00684836105560067,5.41810943361239e-06
PLA2G15,Phospholipase A2 group XV,Physical activities,X6162#3.Types of transport used (excluding work)_Public transport,51140,0.00608844726764894,0.00293498376718956,0.000335879083957403,0.0118410154513405,0.0380434717752396
PLA2G15,Phospholipase A2 group XV,Physical activities,X6162#4.Types of transport used (excluding work)_Cycle,51140,-0.0389998715050472,0.00530567574903822,-0.0493989959731622,-0.0286007470369323,2.00267065490173e-13
PLA2G15,Phospholipase A2 group XV,Physical activities,X6164#1.Types of physical activity in last 4 weeks_Walking for pleasure (not as a means of transport),51175,-0.0272409320215945,0.00292129109176286,-0.0329666625614497,-0.0215152014817393,1.15293353751571e-20
PLA2G15,Phospholipase A2 group XV,Physical activities,X6164#3.Types of physical activity in last 4 weeks_Strenuous sports,51175,-0.0484334166026573,0.00455130774664452,-0.0573539797860805,-0.039512853419234,2.03264441996285e-26
PLA2G15,Phospholipase A2 group XV,Health and medical history,X6179#1.Mineral and other dietary supplements_Fish oil (including cod liver oil),51379,-0.0232129706976604,0.00288004850657078,-0.0288578657705391,-0.0175680756247816,7.79740405768099e-16
PLA2G15,Phospholipase A2 group XV,Health and medical history,X6179#2.Mineral and other dietary supplements_Glucosamine,51379,-0.0295475161908948,0.0034078855143235,-0.0362269717989689,-0.0228680605828208,4.43168025223139e-18
PLA2G15,Phospholipase A2 group XV,Health and medical history,X6179#3.Mineral and other dietary supplements_Calcium,51379,-0.00574290023454587,0.0051470402263199,-0.0158310990781329,0.00434529860904114,0.264526886137288
PLA2G15,Phospholipase A2 group XV,Health and medical history,X6179#4.Mineral and other dietary supplements_Zinc,51379,-0.0290536113862961,0.00654548074871997,-0.0418827536537872,-0.0162244691188049,9.06800771332479e-06
PLA2G15,Phospholipase A2 group XV,Health and medical history,X6179#5.Mineral and other dietary supplements_Iron,51379,0.0178987647306304,0.00711344697214038,0.00395640866523525,0.0318411207960255,0.0118662352658849
PLA2G15,Phospholipase A2 group XV,Health and medical history,X6179#6.Mineral and other dietary supplements_Selenium,51379,-0.0423478324883991,0.00850427792014256,-0.0590162172118785,-0.0256794477649196,6.39246256213712e-07
PLA2G15,Phospholipase A2 group XV,Physical measures,"X78.Heel bone mineral density (BMD) T-score, automated",29223,-0.0122480882793628,0.00180911477690214,-0.0157939532420911,-0.00870222331663465,1.31027500851638e-11
PLA2G15,Phospholipase A2 group XV,Physical activities,X864.Number of days or week walked 10+ minutes,50500,-0.0934619613262724,0.0276869715901439,-0.147728425642954,-0.0391954970095904,0.000736927944217688
PLA2G15,Phospholipase A2 group XV,Physical activities,X874.Duration of walks,43731,-0.00521223173410262,0.00141350131146918,-0.00798269430458221,-0.00244176916362302,0.00022677632251334
PLA2G15,Phospholipase A2 group XV,Physical activities,X884.Number of days or week of moderate physical activity 10+ minutes,48820,-0.203114138094524,0.0269620173622853,-0.255959692124604,-0.150268584064445,5.03084319359014e-14
PLA2G15,Phospholipase A2 group XV,Physical activities,X894.Duration of moderate activity,37813,-0.0844140554002472,0.0328468466761365,-0.148793874885475,-0.0200342359150196,0.0101757391460879
PLA2G15,Phospholipase A2 group XV,Physical activities,X90087.No-wear time bias adjusted average acceleration,10804,-0.0134026108370362,0.00291401878875449,-0.019114087662995,-0.00769113401107745,4.28621809530221e-06
PLA2G15,Phospholipase A2 group XV,Physical activities,X904.Number of days or week of vigorous physical activity 10+ minutes,48733,-0.370452607987898,0.0279568607402606,-0.425248055038809,-0.315657160936988,5.23229835806419e-40
PLA2G15,Phospholipase A2 group XV,Physical activities,X914.Duration of vigorous activity,27299,-0.00570658714280963,0.00174982380386621,-0.00913624179838741,-0.00227693248723185,0.00111064027463089
